CA2326579A1 - Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens - Google Patents
Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens Download PDFInfo
- Publication number
- CA2326579A1 CA2326579A1 CA002326579A CA2326579A CA2326579A1 CA 2326579 A1 CA2326579 A1 CA 2326579A1 CA 002326579 A CA002326579 A CA 002326579A CA 2326579 A CA2326579 A CA 2326579A CA 2326579 A1 CA2326579 A1 CA 2326579A1
- Authority
- CA
- Canada
- Prior art keywords
- therapeutic treatment
- information
- medical condition
- treatment regimen
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000011269 treatment regimen Methods 0.000 title claims abstract 151
- 230000001225 therapeutic effect Effects 0.000 title claims abstract 150
- 238000000034 method Methods 0.000 title claims abstract 49
- 238000004590 computer program Methods 0.000 title claims abstract 48
- 201000010099 disease Diseases 0.000 claims abstract 98
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 98
- 238000011282 treatment Methods 0.000 claims abstract 14
- 208000031886 HIV Infections Diseases 0.000 claims abstract 13
- 239000000470 constituent Substances 0.000 claims abstract 7
- 229940079593 drug Drugs 0.000 claims 43
- 239000003814 drug Substances 0.000 claims 43
- 230000000798 anti-retroviral effect Effects 0.000 claims 12
- 230000001684 chronic effect Effects 0.000 claims 8
- 208000024172 Cardiovascular disease Diseases 0.000 claims 6
- 206010013700 Drug hypersensitivity Diseases 0.000 claims 6
- 206010061822 Drug intolerance Diseases 0.000 claims 6
- 102000001554 Hemoglobins Human genes 0.000 claims 6
- 108010054147 Hemoglobins Proteins 0.000 claims 6
- 241000725303 Human immunodeficiency virus Species 0.000 claims 6
- 208000019693 Lung disease Diseases 0.000 claims 6
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 208000012902 Nervous system disease Diseases 0.000 claims 6
- 206010033645 Pancreatitis Diseases 0.000 claims 6
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims 6
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims 6
- 230000002411 adverse Effects 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 6
- DCSUBABJRXZOMT-IRLDBZIGSA-N cisapride Chemical compound C([C@@H]([C@@H](CC1)NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)OC)N1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-IRLDBZIGSA-N 0.000 claims 6
- 229960005132 cisapride Drugs 0.000 claims 6
- DCSUBABJRXZOMT-UHFFFAOYSA-N cisapride Natural products C1CC(NC(=O)C=2C(=CC(N)=C(Cl)C=2)OC)C(OC)CN1CCCOC1=CC=C(F)C=C1 DCSUBABJRXZOMT-UHFFFAOYSA-N 0.000 claims 6
- 201000005311 drug allergy Diseases 0.000 claims 6
- 208000006454 hepatitis Diseases 0.000 claims 6
- 231100000283 hepatitis Toxicity 0.000 claims 6
- 229960001936 indinavir Drugs 0.000 claims 6
- CBVCZFGXHXORBI-PXQQMZJSSA-N indinavir Chemical compound C([C@H](N(CC1)C[C@@H](O)C[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H]2C3=CC=CC=C3C[C@H]2O)C(=O)NC(C)(C)C)N1CC1=CC=CN=C1 CBVCZFGXHXORBI-PXQQMZJSSA-N 0.000 claims 6
- 230000000977 initiatory effect Effects 0.000 claims 6
- 230000003907 kidney function Effects 0.000 claims 6
- 230000003908 liver function Effects 0.000 claims 6
- 201000001119 neuropathy Diseases 0.000 claims 6
- 230000007823 neuropathy Effects 0.000 claims 6
- 210000000440 neutrophil Anatomy 0.000 claims 6
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims 6
- 208000033808 peripheral neuropathy Diseases 0.000 claims 6
- 230000000069 prophylactic effect Effects 0.000 claims 6
- 229960000351 terfenadine Drugs 0.000 claims 6
- 208000019206 urinary tract infection Diseases 0.000 claims 6
- 230000003612 virological effect Effects 0.000 claims 6
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/20—ICT specially adapted for the handling or processing of medical references relating to practices or guidelines
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S706/00—Data processing: artificial intelligence
- Y10S706/902—Application using ai with detail of the ai system
- Y10S706/924—Medical
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Pathology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Bioethics (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen for a known disease such as HIV infection are disclosed. The method comprises (a) providing patient information to a computing device (11) (the computer device comprising: a first knowledge base comprising a plurality of different therapeutic treatment regimens for the disease (11); a second knowledge base comprising a plurality of expert rules for selecting a therapeutic treatment regimen for the disease (11); and a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of the different therapeutic treatment regimens (11); and (b) generating in the computing device a listing (preferably a ranked listing) of therapeutic treatment regimens for the patient (12); and (c) generating in the computing device advisory information (13) for one or more treatment regimens in the listing based on the patient information and the expert rules.
Claims (132)
1. A method for guiding the selection of a therapeutic treatment regimen for a patient with a known disease or medical condition, said method comprising:
(a) providing patient information to a computing device comprising:
a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition;
a second knowledge base comprising a plurality of expert rules for evaluating and selecting a therapeutic treatment regimen for said disease or medical condition;
a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of said different therapeutic treatment regimens; and (b) generating in said computing device a ranked listing of available therapeutic treatment regimens for said patient; and (c) generating in said computing device advisory information for one or more therapeutic treatment regimens in said ranked listing based on said patient information and said expert rules.
(a) providing patient information to a computing device comprising:
a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition;
a second knowledge base comprising a plurality of expert rules for evaluating and selecting a therapeutic treatment regimen for said disease or medical condition;
a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of said different therapeutic treatment regimens; and (b) generating in said computing device a ranked listing of available therapeutic treatment regimens for said patient; and (c) generating in said computing device advisory information for one or more therapeutic treatment regimens in said ranked listing based on said patient information and said expert rules.
2. A method according to claim 1, further comprising the steps of:
(d) entering a user-defined therapeutic treatment regimen for said disease or medical condition that is not included in said first knowledge base;
(e) generating in said computing device advisory information for said user-defined combination therapeutic treatment regimen.
(d) entering a user-defined therapeutic treatment regimen for said disease or medical condition that is not included in said first knowledge base;
(e) generating in said computing device advisory information for said user-defined combination therapeutic treatment regimen.
A method according to claim 1, further comprising the steps of:
(f) entering a non-recommended therapeutic treatment regimen for said disease or medical condition that is included in said first knowledge base but not recommended from said ranked listing; and (g) generating in said computing device advisory information for said non-recommended therapeutic treatment regimen, said advisory information including at least one reason for non-recommendation of said therapeutic treatment regimen.
(f) entering a non-recommended therapeutic treatment regimen for said disease or medical condition that is included in said first knowledge base but not recommended from said ranked listing; and (g) generating in said computing device advisory information for said non-recommended therapeutic treatment regimen, said advisory information including at least one reason for non-recommendation of said therapeutic treatment regimen.
4. A method according to claim 1, said patient information comprising gender, age, weight, CD4 information, viral load information, HIV genotype and phenotype information, hemoglobin information, neuropathy information, neutrophil information, pancreatitis, hepatic function, renal function, drug allergy and intolerance information.
5. A method according to claim 1, said patient information including prior therapeutic treatment regimen information
6. A method according to claim 1, wherein said patient information includes prior patient information stored in said computing device.
7. A method according to claim 1, said advisory information including:
warnings to take the patient off a contraindicated drug before initiating a corresponding therapeutic treatment regimen; and information clinically useful to implement a corresponding therapeutic treatment regimen.
warnings to take the patient off a contraindicated drug before initiating a corresponding therapeutic treatment regimen; and information clinically useful to implement a corresponding therapeutic treatment regimen.
8. A method according to claim 1, wherein said computing device comprises a fourth knowledge base comprising patient therapeutic treatment regimen history, said advisory information including previous therapeutic treatment regimen information extracted from said fourth knowledge base.
9. A method according to claim 7, wherein said known disease or medical condition is HIV-1 infection, said therapeutic treatment regimen includes antiretroviral drugs, and said therapeutic treatment regimen includes contraindicated or potentially adversely interacting non-antiretroviral drugs.
10. A method according to claim 7, wherein said therapeutic treatment regimen includes a protease inhibitor, and said contraindicated drug is terfenadine.
11. A method according to claim 7, wherein said therapeutic treatment regimen includes indinavir and said contraindicated drug is cisapride.
12. A method according to claim 1, wherein said known disease or medical condition is one where multiple prophylactic or therapeutic treatment regimens are available to be used singly or in combination in the treatment of said disease.
13. A method according to claim 1, wherein said known disease or medical condition is a cardiovascular disease.
14. A method according to claim 1, wherein said known disease or medical condition is a pulmonary disease.
15. A method according to claim 1, wherein said known disease or medical condition is a neurologic disease.
16. A method according to claim 1, wherein said known disease or medical condition is cancer.
17. A method according to claim 1, wherein said known disease or medical condition is a urinary tract infection.
18. A method according to claim 1, wherein said known disease or medical condition is hepatitis.
19. A method according to claim 1, wherein said known disease or medical condition is HIV-1 infection.
20. A method according to claim 1, wherein said first knowledge base comprises a plurality of different combination therapeutic treatment regimens.
21. A method according to claim 1, wherein drug dosage information is recommended and adjusted if necessary depending upon said patient information.
22. A method according to claim 1, further comprising the step of:
(d) accessing, via said computing device, information for one or more therapeutic treatment regimens from a drug reference source.
(d) accessing, via said computing device, information for one or more therapeutic treatment regimens from a drug reference source.
23. A system for guiding the selection of a therapeutic treatment regimen for a patient with a known disease or medical condition, said system comprising:
(a) a computing device comprising:
a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition;
a second knowledge base comprising a plurality of expert rules for selecting a therapeutic treatment regimen for said disease or medical condition;
a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of said different therapeutic treatment regimens; and (b) means for providing patient information to said computing device;
(c) means for generating in said computing device a ranked listing of therapeutic treatment regimens for said patient; and (d) means for generating in said computing device advisory information for one or more therapeutic treatment regimens in said ranked listing based on said patient information and said expert rules.
(a) a computing device comprising:
a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition;
a second knowledge base comprising a plurality of expert rules for selecting a therapeutic treatment regimen for said disease or medical condition;
a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of said different therapeutic treatment regimens; and (b) means for providing patient information to said computing device;
(c) means for generating in said computing device a ranked listing of therapeutic treatment regimens for said patient; and (d) means for generating in said computing device advisory information for one or more therapeutic treatment regimens in said ranked listing based on said patient information and said expert rules.
24. A system according to claim 23, further comprising:
(e) means for entering a user-defined therapeutic treatment regimen for said disease or medical condition that is not generated or displayed via said first knowledge base;
(f) means for generating in said computing device advisory information for said user-defined combination therapeutic treatment regimen.
(e) means for entering a user-defined therapeutic treatment regimen for said disease or medical condition that is not generated or displayed via said first knowledge base;
(f) means for generating in said computing device advisory information for said user-defined combination therapeutic treatment regimen.
25. A system according to claim 23, further comprising:
(f) means for entering a non-recommended therapeutic treatment regimen for said disease or medical condition that is included in said first knowledge base but not recommended from said ranked listing; and (g) means for generating in said computing device advisory information for said non-recommended therapeutic treatment regimen, said advisory information including at least one reason for non-recommendation of said therapeutic treatment regimen.
(f) means for entering a non-recommended therapeutic treatment regimen for said disease or medical condition that is included in said first knowledge base but not recommended from said ranked listing; and (g) means for generating in said computing device advisory information for said non-recommended therapeutic treatment regimen, said advisory information including at least one reason for non-recommendation of said therapeutic treatment regimen.
26. A system according to claim 23, said patient information comprising gender, age, weight, CD4 information, viral load information, HIV
genotype and phenotype information, hemoglobin information, neuropathy information, neutrophil information, pancreatitis, hepatic function, renal function, drug allergy and intolerance information.
genotype and phenotype information, hemoglobin information, neuropathy information, neutrophil information, pancreatitis, hepatic function, renal function, drug allergy and intolerance information.
27. A system according to claim 23, said patient information including prior therapeutic treatment regimen information.
28. A system according to claim 23, wherein said patient information includes prior patient information stored in said computing device.
29. A system according to claim 23, said advisory information including:
warnings to take the patient off a contraindicated drug before initiating a corresponding therapeutic treatment regimen; and information clinically useful to implement a corresponding therapeutic treatment regimen.
warnings to take the patient off a contraindicated drug before initiating a corresponding therapeutic treatment regimen; and information clinically useful to implement a corresponding therapeutic treatment regimen.
30. A system according to claim 23, wherein said computing device comprises a fourth knowledge base comprising patient therapeutic treatment regimen history, said advisory information including previous therapeutic treatment regimen information extracted from said fourth knowledge base.
31. A system according to claim 29, wherein said known disease or medical condition is HIV-1 infection, said therapeutic treatment regimen includes antiretroviral drugs, and said therapeutic treatment regimen includes contraindicated or potentially adversely interacting non-antiretroviral drugs.
32. A system according to claim 29, wherein said therapeutic treatment regimen includes a protease inhibitor, and said contraindicated drug is terfenadine.
33. A system according to claim 29, wherein said therapeutic treatment regimen includes indinavir and said contraindicated drug is cisapride.
34. A system according to claim 23, wherein said known disease or medical condition is one where multiple prophylactic therapeutic treatment regimens are available to be used singly or in combination in the treatment of said disease or medical condition.
35. A system according to claim 23, wherein said known disease or medical condition is a cardiovascular disease.
36. A system according to claim 23, wherein said known disease or medical condition is a pulmonary disease.
37. A system according to claim 23, wherein said known disease or medical condition is a neurologic disease.
38. A system according to claim 23, wherein said known disease or medical condition is cancer.
39. A system according to claim 23, wherein said known disease or medical condition is a urinary tract infection.
40. A system according to claim 23, wherein said known disease or medical condition is hepatitis.
41. A system according to claim 23, wherein said known disease or medical condition is HIV-1 infection.
42. A system according to claim 23, wherein said first knowledge base comprises a plurality of different combination therapeutic treatment regimens.
43. A system according to claim 23, wherein drug dosage information is recommended and adjusted if necessary depending upon said patient information.
44. A system according to claim 23, further comprising:
(e) means for accessing, via said computing device, information for one or more therapeutic treatment regimens from a standard drug reference source.
(e) means for accessing, via said computing device, information for one or more therapeutic treatment regimens from a standard drug reference source.
45. A computer program product for guiding the selection of a therapeutic treatment regimen for a patient with a known disease or medical condition, said computer program product comprising a computer usable storage medium having computer readable program code means embodied in the medium, the computer readable program code means comprising:
(a) computer readable program code means for generating:
a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition;
a second knowledge base comprising a plurality of expert rules for selecting a therapeutic treatment regimen for said disease or medical condition;
a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of said different therapeutic treatment regimens; and (b) computer readable program code means for providing patient information;
(c) computer readable program code means for generating a ranked listing of available therapeutic treatment regimens for said patient; and (d) computer readable program code means for generating advisory information for one or more therapeutic treatment regimens in said ranked listing based on said patient information and said expert rules.
(a) computer readable program code means for generating:
a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition;
a second knowledge base comprising a plurality of expert rules for selecting a therapeutic treatment regimen for said disease or medical condition;
a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of said different therapeutic treatment regimens; and (b) computer readable program code means for providing patient information;
(c) computer readable program code means for generating a ranked listing of available therapeutic treatment regimens for said patient; and (d) computer readable program code means for generating advisory information for one or more therapeutic treatment regimens in said ranked listing based on said patient information and said expert rules.
46. A computer program product according to claim 45, further comprising:
(e) computer readable program code means for entering a user-defined therapeutic treatment regimen for said disease or medical condition that is not generated or displayed via said first knowledge base;
(f) computer readable program code means for advisory information for said user-defined combination therapeutic treatment regimen.
(e) computer readable program code means for entering a user-defined therapeutic treatment regimen for said disease or medical condition that is not generated or displayed via said first knowledge base;
(f) computer readable program code means for advisory information for said user-defined combination therapeutic treatment regimen.
47. A computer program product according to claim 46, further comprising:
(g) computer readable program code means for entering a non-recommended therapeutic treatment regimen for said disease or medical condition that is included in said first knowledge base but not recommended from said ranked listing; and (h) computer readable program code means for generating advisory information for said non-recommended therapeutic treatment regimen, said advisory information including at least one reason for non-recommendation of said therapeutic treatment regimen.
(g) computer readable program code means for entering a non-recommended therapeutic treatment regimen for said disease or medical condition that is included in said first knowledge base but not recommended from said ranked listing; and (h) computer readable program code means for generating advisory information for said non-recommended therapeutic treatment regimen, said advisory information including at least one reason for non-recommendation of said therapeutic treatment regimen.
48. A computer program product according to claim 45, said patient information comprising gender, age, weight, CD4 information, viral load information, HIV genotype and phenotype information, hemoglobin information, neuropathy information, neutrophil information, pancreatitis, hepatic function, renal function, drug allergy and intolerance information, and information for drug treatments for other conditions.
49. A computer program product according to claim 45, said patient information including prior therapeutic treatment regimen information.
50. A computer program product according to claim 45, wherein said patient information includes prior patient information.
51. A computer program product according to claim 45, said advisory information including:
warnings to take the patient off a contraindicated drug before initiating a corresponding therapeutic treatment regimen; and information clinically useful to implement a corresponding therapeutic treatment regimen.
warnings to take the patient off a contraindicated drug before initiating a corresponding therapeutic treatment regimen; and information clinically useful to implement a corresponding therapeutic treatment regimen.
52. A computer program product according to claim 45 wherein said computer readable program code means comprises computer readable program code means for generating a fourth knowledge base comprising patient therapeutic treatment regimen history, said advisory information including previous therapeutic treatment regimen information extracted from said fourth knowledge base.
53. A computer program product according to claim 51, wherein said known disease or medical condition is HIV-1 infection, said therapeutic treatment regimen includes antiretroviral drugs, and said therapeutic treatment regimen includes contraindicated or potentially adversely interacting non-antiretroviral drugs.
54. A computer program product according to claim 51, wherein said therapeutic treatment regimen includes a protease inhibitor, and said contraindicated drug is terfenadine.
55. A computer program product according to claim 51, wherein said therapeutic treatment regimen includes indinavir and said contraindicated drug is cisapride.
56. A computer program product according to claim 45, wherein said known disease or medical condition is one where multiple prophylactic therapeutic treatment regimens are available to be used singly or in combination in the treatment of said disease or medical condition.
57. A computer program product according to claim 45, wherein said known disease or medical condition is a cardiovascular disease.
58. A computer program product according to claim 45, wherein said known disease or medical condition is a pulmonary disease.
59. A computer program product according to claim 45, wherein said known disease or medical condition is a neurologic disease.
60. A computer program product according to claim 45, wherein said known disease or medical condition is cancer.
61. A computer program product according to claim 45, wherein said known disease or medical condition is a urinary tract infection.
62. A computer program product according to claim 45, wherein said known disease or medical condition is hepatitis.
63. A computer program product according to claim 45, wherein said known disease or medical condition is HIV-1 infection.
64. A computer program product according to claim 45, wherein said first knowledge base comprises a plurality of different combination therapeutic treatment regimens.
65. A computer program product according to claim 45, wherein drug dosage information is recommended and adjusted if necessary depending upon said patient information.
66. A computer program product according to claim 45, further comprising:
(e) computer readable program code means for accessing information for one or more therapeutic treatment regimens from a standard drug reference source.
(e) computer readable program code means for accessing information for one or more therapeutic treatment regimens from a standard drug reference source.
67. A method for guiding the selection of a therapeutic treatment regimen for a patient with a chronic known disease or medical condition, said method comprising:
(a) providing patient information to a computing device, said patient information including prior therapeutic treatment regimen information for said chronic known disease or medical condition, said computer device comprising:
a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition;
a second knowledge base comprising a plurality of expert rules for evaluating and selecting a therapeutic treatment regimen for said disease or medical condition;
a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of said different therapeutic treatment regimens; and (b) generating in said computing device from said patient information and said first knowledge base a listing of available therapeutic treatment regimens for said patient; and (c) generating in said computing device advisory information for one or more therapeutic treatment regimens for said patient in said listing based on said patient information and said expert rules.
(a) providing patient information to a computing device, said patient information including prior therapeutic treatment regimen information for said chronic known disease or medical condition, said computer device comprising:
a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition;
a second knowledge base comprising a plurality of expert rules for evaluating and selecting a therapeutic treatment regimen for said disease or medical condition;
a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of said different therapeutic treatment regimens; and (b) generating in said computing device from said patient information and said first knowledge base a listing of available therapeutic treatment regimens for said patient; and (c) generating in said computing device advisory information for one or more therapeutic treatment regimens for said patient in said listing based on said patient information and said expert rules.
68. A method according to claim 67, further comprising the steps of:
(d) entering a user-defined therapeutic treatment regimen for said disease or medical condition that is not included in said first knowledge base;
(e) generating in said computing device advisory information for said user-defined combination therapeutic treatment regimen.
(d) entering a user-defined therapeutic treatment regimen for said disease or medical condition that is not included in said first knowledge base;
(e) generating in said computing device advisory information for said user-defined combination therapeutic treatment regimen.
69. A method according to claim 67, further comprising the steps of:
entering a non-recommended therapeutic treatment regimen for said disease or medical condition that is included in said first knowledge base but not recommended from said listing; and (g) generating in said computing device advisory information for said non-recommended therapeutic treatment regimen, said advisory information including at least one reason for non-recommendation of said therapeutic treatment regimen.
entering a non-recommended therapeutic treatment regimen for said disease or medical condition that is included in said first knowledge base but not recommended from said listing; and (g) generating in said computing device advisory information for said non-recommended therapeutic treatment regimen, said advisory information including at least one reason for non-recommendation of said therapeutic treatment regimen.
70. A method according to claim 67, said patient information comprising gender, age, weight, CD4 information, viral load information, HIV
genotype and phenotype information, hemoglobin information, neuropathy information, neutrophil information, pancreatitis, hepatic function, renal function, drug allergy and intolerance information.
genotype and phenotype information, hemoglobin information, neuropathy information, neutrophil information, pancreatitis, hepatic function, renal function, drug allergy and intolerance information.
71. A method according to claim 67, wherein said listing of available therapeutic treatment regimens for said patient comprises a ranked listing of available therapeutic treatment regimens for said patient.
72. A method according to claim 67, wherein said patient information includes prior patient information stored in said computing device.
73. A method according to claim 67, said advisory information including:
warnings to take the patient off a contraindicated drug before initiating a corresponding therapeutic treatment regimen; and information clinically useful to implement a corresponding therapeutic treatment regimen.
warnings to take the patient off a contraindicated drug before initiating a corresponding therapeutic treatment regimen; and information clinically useful to implement a corresponding therapeutic treatment regimen.
74. A method according to claim 67, wherein said computing device comprises a fourth knowledge base comprising patient therapeutic treatment regimen history, said advisory information including previous therapeutic treatment regimen information extracted from said fourth knowledge base.
75. A method according to claim 73, wherein said known disease or medical condition is HIV-1 infection, said therapeutic treatment regimen includes antiretroviral drugs, and said therapeutic treatment regimen includes contraindicated or potentially adversely interacting non-antiretroviral drugs.
76. A method according to claim 73, wherein said therapeutic treatment regimen includes a protease inhibitor, and said contraindicated drug is terfenadine.
77. A method according to claim 73, wherein said therapeutic treatment regimen includes indinavir and said contraindicated drug is cisapride.
78. A method according to claim 67, wherein said known disease or medical condition is one where multiple prophylactic or therapeutic treatment regimens are available to be used singly or in combination in the treatment of said disease.
79. A method according to claim 67, wherein said known disease or medical condition is a cardiovascular disease.
80. A method according to claim 67, wherein said known disease or medical condition is a pulmonary disease.
81. A method according to claim 67, wherein said known disease or medical condition is a neurologic disease.
82. A method according to claim 67, wherein said known disease or medical condition is cancer.
83. A method according to claim 67, wherein said known disease or medical condition is a urinary tract infection.
84. A method according to claim 67, wherein said known disease or medical condition is hepatitis.
85. A method according to claim 67, wherein said known disease or medical condition is HIV-1 infection.
86. A method according to claim 67, wherein said first knowledge base comprises a plurality of different combination therapeutic treatment regimens.
87. A method according to claim 67, wherein drug dosage information is recommended and adjusted if necessary depending upon said patient information.
88. A method according to claim 67, further comprising the step of:
(d) accessing, via said computing device, information for one or more therapeutic treatment regimens from a drug reference source.
(d) accessing, via said computing device, information for one or more therapeutic treatment regimens from a drug reference source.
89. A system for guiding the selection of a therapeutic treatment regimen for a patient with a chronic known disease or medical condition, said system comprising:
(a) a computing device comprising:
a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition;
a second knowledge base comprising a plurality of expert rules for selecting a therapeutic treatment regimen for said disease or medical condition;
a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of said different therapeutic treatment regimens; and (b) means for providing patient information to said computing device, said patient information including prior therapeutic treatment regimen information for said chronic known disease or medical condition;
(c) means for generating in said computing device from said patient information and said first knowledge base a listing of therapeutic treatment regimens for said patient for said chronic known disease or medical condition;
and (d) means for generating in said computing device advisory information for one or more therapeutic treatment regimens for said patient in said listing based on said patient information and said expert rules.
(a) a computing device comprising:
a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition;
a second knowledge base comprising a plurality of expert rules for selecting a therapeutic treatment regimen for said disease or medical condition;
a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of said different therapeutic treatment regimens; and (b) means for providing patient information to said computing device, said patient information including prior therapeutic treatment regimen information for said chronic known disease or medical condition;
(c) means for generating in said computing device from said patient information and said first knowledge base a listing of therapeutic treatment regimens for said patient for said chronic known disease or medical condition;
and (d) means for generating in said computing device advisory information for one or more therapeutic treatment regimens for said patient in said listing based on said patient information and said expert rules.
90. A system according to claim 89, further comprising:
(e) means for entering a user-defined therapeutic treatment regimen for said disease or medical condition that is not generated or displayed via said first knowledge base;
(f) means for generating in said computing device advisory information for said user-defined combination therapeutic treatment regimen.
(e) means for entering a user-defined therapeutic treatment regimen for said disease or medical condition that is not generated or displayed via said first knowledge base;
(f) means for generating in said computing device advisory information for said user-defined combination therapeutic treatment regimen.
91. A system according to claim 89, further comprising:
(f) means for entering a non-recommended therapeutic treatment regimen for said disease or medical condition that is included in said first knowledge base but not recommended from said listing; and (g) means for generating in said computing device advisory information for said non-recommended therapeutic treatment regimen, said advisory information including at least one reason for non-recommendation of said therapeutic treatment regimen.
(f) means for entering a non-recommended therapeutic treatment regimen for said disease or medical condition that is included in said first knowledge base but not recommended from said listing; and (g) means for generating in said computing device advisory information for said non-recommended therapeutic treatment regimen, said advisory information including at least one reason for non-recommendation of said therapeutic treatment regimen.
92. A system according to claim 89, said patient information comprising gender, age, weight, CD4 information, viral load information, HIV
genotype and phenotype information, hemoglobin information, neuropathy information, neutrophil information, pancreatitis, hepatic function, renal function, drug allergy and intolerance information.
genotype and phenotype information, hemoglobin information, neuropathy information, neutrophil information, pancreatitis, hepatic function, renal function, drug allergy and intolerance information.
93. A system according to claim 89, wherein said listing of available therapeutic treatment regimens for said patient comprises a ranked listing of available therapeutic treatment regimens for said patient.
94. A system according to claim 89, wherein said patient information includes prior patient information stored in said computing device.
95. A system according to claim 89, said advisory information including:
warnings to take the patient off a contraindicated drug before initiating a corresponding therapeutic treatment regimen; and information clinically useful to implement a corresponding therapeutic treatment regimen.
warnings to take the patient off a contraindicated drug before initiating a corresponding therapeutic treatment regimen; and information clinically useful to implement a corresponding therapeutic treatment regimen.
96. A system according to claim 89, wherein said computing device comprises a fourth knowledge base comprising patient therapeutic treatment regimen history, said advisory information including previous therapeutic treatment regimen information extracted from said fourth knowledge base.
97. A system according to claim 95, wherein said known disease or medical condition is HIV-1 infection, said therapeutic treatment regimen includes antiretroviral drugs, and said therapeutic treatment regimen includes contraindicated or potentially adversely interacting non-antiretroviral drugs.
98. A system according to claim 95, wherein paid therapeutic treatment regimen includes a protease inhibitor, and said contraindicated drug is terfenadine.
99. A system according to claim 95, wherein said therapeutic treatment regimen includes indinavir and said contraindicated drug is cisapride.
100. A system according to claim 89, wherein said known disease or medical condition is one where multiple prophylactic therapeutic treatment regimens are available to be used singly or in combination in the treatment of said disease or medical condition.
101. A system according to claim 89, wherein said known disease or medical condition is a cardiovascular disease.
102. A system according to claim 89, wherein said known disease or medical condition is a pulmonary disease.
103. A system according to claim 89, wherein said known disease or medical condition is a neurologic disease.
104. A system according to claim 89, wherein said known disease or medical condition is cancer.
105. A system according to claim 89, wherein said known disease or medical condition is a urinary tract infection.
106. A system according to claim 89, wherein said known disease or medical condition is hepatitis.
107. A system according to claim 89, wherein said known disease or medical condition is HIV-1 infection.
108. A system according to claim 89, wherein said first knowledge base comprises a plurality of different combination therapeutic treatment regimens.
109. A system according to claim 89, wherein drug dosage information is recommended and adjusted if necessary depending upon said patient information.
110. A system according to claim 89, further comprising:
(e) means for accessing, via said computing device, information for one or more therapeutic treatment regimens from a standard drug reference source.
(e) means for accessing, via said computing device, information for one or more therapeutic treatment regimens from a standard drug reference source.
111. A computer program product for guiding the selection of a therapeutic treatment regimen for a patient with a chronic known disease or medical condition, said computer program product comprising a computer usable storage medium having computer readable program code means embodied in the medium, the computer readable program code means comprising:
(a) computer readable program code means for generating:
a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition;
a second knowledge base comprising a plurality of expert rules for selecting a therapeutic treatment regimen for said disease or medical condition;
a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of said different therapeutic treatment regimens; and (b) computer readable program code means for providing patient information, said patient information including prior therapeutic treatment regimen information for said chronic known disease or medical condition;
(c) computer readable program code means for generating from said patient information and said first knowledge base a listing of available therapeutic treatment regimens for said patient for said chronic known disease or medical condition; and (d) computer readable program code means for generating advisory information for one or more therapeutic treatment regimens for said patient in said listing based on said patient information and said expert rules.
(a) computer readable program code means for generating:
a first knowledge base comprising a plurality of different therapeutic treatment regimens for said disease or medical condition;
a second knowledge base comprising a plurality of expert rules for selecting a therapeutic treatment regimen for said disease or medical condition;
a third knowledge base comprising advisory information useful for the treatment of a patient with different constituents of said different therapeutic treatment regimens; and (b) computer readable program code means for providing patient information, said patient information including prior therapeutic treatment regimen information for said chronic known disease or medical condition;
(c) computer readable program code means for generating from said patient information and said first knowledge base a listing of available therapeutic treatment regimens for said patient for said chronic known disease or medical condition; and (d) computer readable program code means for generating advisory information for one or more therapeutic treatment regimens for said patient in said listing based on said patient information and said expert rules.
112. A computer program product according to claim 111, further comprising:
(e) computer readable program code means for entering a user-defined therapeutic treatment regimen for said disease or medical condition that is not generated or displayed via said first knowledge base;
(f) computer readable program code means for generating advisory information for said user-defined combination therapeutic treatment regimen.
(e) computer readable program code means for entering a user-defined therapeutic treatment regimen for said disease or medical condition that is not generated or displayed via said first knowledge base;
(f) computer readable program code means for generating advisory information for said user-defined combination therapeutic treatment regimen.
113. A computer program product according to claim 112, further comprising:
(g) computer readable program code means for entering a non-recommended therapeutic treatment regimen for said disease or medical condition that is included in said first knowledge base but not recommended from said listing; and (h) computer readable program code means for advisory information for said non-recommended therapeutic treatment regimen, said advisory information including at least one reason for non-recommendation of said therapeutic treatment regimen.
(g) computer readable program code means for entering a non-recommended therapeutic treatment regimen for said disease or medical condition that is included in said first knowledge base but not recommended from said listing; and (h) computer readable program code means for advisory information for said non-recommended therapeutic treatment regimen, said advisory information including at least one reason for non-recommendation of said therapeutic treatment regimen.
114. A computer program product according to claim 111, said patient information comprising gender, age, weight, CD4 information, viral load information, HIV genotype and phenotype information, hemoglobin information, neuropathy information, neutrophil information, pancreatitis, hepatic function, renal function, drug allergy and intolerance information.
115. A computer program product according to claim 111, wherein said patient information includes prior patient information.
116. A computer program product according to claim 111, said advisory information including:
warnings to take the patient off a contraindicated drug before initiating a corresponding therapeutic treatment regimen; and information clinically useful to implement a corresponding therapeutic treatment regimen.
warnings to take the patient off a contraindicated drug before initiating a corresponding therapeutic treatment regimen; and information clinically useful to implement a corresponding therapeutic treatment regimen.
117. A computer program product according to claim 111 wherein said computer readable program code means comprises computer readable program code means for generating a fourth knowledge base comprising patient therapeutic treatment regimen history, said advisory information including previous therapeutic treatment regimen information extracted from said fourth knowledge base.
118. A computer program product according to claim 116, wherein said known disease or medical condition is HIV-1 infection, said therapeutic treatment regimen includes antiretroviral drugs, and said therapeutic treatment regimen includes contraindicated or potentially adversely interacting non-antiretroviral drugs.
119. A computer program product according to claim 116, wherein said therapeutic treatment regimen includes a protease inhibitor, and said contraindicated drug is terfenadine.
120. A computer program product according to claim 116, wherein said therapeutic treatment regimen includes indinavir and said contraindicated drug is cisapride.
121. A computer program product according to claim 111, wherein said known disease or medical condition is one where multiple prophylactic therapeutic treatment regimens are available to be used singly or in combination in the treatment of said disease or medical condition.
122. A computer program product according to claim 111, wherein said known disease or medical condition is a cardiovascular disease.
123. A computer program product according to claim 111, wherein said known disease or medical condition is a pulmonary disease.
124. A computer program product according to claim 111, wherein said known disease or medical condition is a neurologic disease.
125. A computer program product according to claim 111, wherein said known disease or medical condition is cancer.
126. A computer program product according to claim 111, wherein said known disease or medical condition is a urinary tract infection.
127. A computer program product according to claim 111, wherein said known disease or medical condition is hepatitis.
128. A computer program product according to claim 111, wherein said known disease or medical condition is HIV-1 infection.
129. A computer program product according to claim 111, wherein said first knowledge base comprises a plurality of different combination therapeutic treatment regimens.
130. A computer program product according to claim 111, wherein drug dosage information is recommended and adjusted if necessary depending upon said patient information.
131. A computer program product according to claim 111, further comprising:
(e) computer readable program code means for accessing information for one or more therapeutic treatment regimens from a standard drug reference source.
(e) computer readable program code means for accessing information for one or more therapeutic treatment regimens from a standard drug reference source.
132. A computer program product according to claim 111, wherein said listing of available therapeutic treatment regimens for said patient is a ranked listing of available therapeutic treatment regimens for said patient.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8062998P | 1998-04-03 | 1998-04-03 | |
US60/080,629 | 1998-04-03 | ||
PCT/US1999/007171 WO1999052025A2 (en) | 1998-04-03 | 1999-04-01 | Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2326579A1 true CA2326579A1 (en) | 1999-10-14 |
CA2326579C CA2326579C (en) | 2011-01-18 |
Family
ID=22158589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2326579A Expired - Fee Related CA2326579C (en) | 1998-04-03 | 1999-04-01 | Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens |
Country Status (9)
Country | Link |
---|---|
US (2) | US6081786A (en) |
EP (1) | EP1068568A4 (en) |
JP (2) | JP2002510817A (en) |
CN (1) | CN1304512A (en) |
AU (1) | AU750822B2 (en) |
BR (1) | BR9909906A (en) |
CA (1) | CA2326579C (en) |
IL (1) | IL138620A0 (en) |
WO (1) | WO1999052025A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007124147A1 (en) | 2006-04-21 | 2007-11-01 | Medtronic Navigation, Inc. | Method and apparatus for optimizing a therapy |
CN111091908A (en) * | 2019-11-19 | 2020-05-01 | 泰康保险集团股份有限公司 | Auxiliary medical scheme generation method and device, storage medium and electronic equipment |
Families Citing this family (443)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030212579A1 (en) * | 2002-05-08 | 2003-11-13 | Brown Stephen J. | Remote health management system |
USRE43433E1 (en) | 1993-12-29 | 2012-05-29 | Clinical Decision Support, Llc | Computerized medical diagnostic and treatment advice system |
US5935060A (en) * | 1996-07-12 | 1999-08-10 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system including list based processing |
US6206829B1 (en) | 1996-07-12 | 2001-03-27 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system including network access |
US5660176A (en) * | 1993-12-29 | 1997-08-26 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system |
US6673314B1 (en) | 1997-02-14 | 2004-01-06 | Nxstage Medical, Inc. | Interactive systems and methods for supporting hemofiltration therapies |
US6852090B2 (en) * | 1997-02-14 | 2005-02-08 | Nxstage Medical, Inc. | Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge |
JP2002512712A (en) | 1997-03-13 | 2002-04-23 | ファースト オピニオン コーポレイション | Disease management system |
US6697783B1 (en) * | 1997-09-30 | 2004-02-24 | Medco Health Solutions, Inc. | Computer implemented medical integrated decision support system |
US6314384B1 (en) * | 1998-03-04 | 2001-11-06 | Gerald E. Goetz | Medication management apparatus |
US8364578B1 (en) | 1998-03-05 | 2013-01-29 | Cgi Technologies And Solutions Inc. | Simultaneous customer/account strategy execution in a decision management system |
US6546545B1 (en) | 1998-03-05 | 2003-04-08 | American Management Systems, Inc. | Versioning in a rules based decision management system |
US6601034B1 (en) | 1998-03-05 | 2003-07-29 | American Management Systems, Inc. | Decision management system which is cross-function, cross-industry and cross-platform |
US6609120B1 (en) | 1998-03-05 | 2003-08-19 | American Management Systems, Inc. | Decision management system which automatically searches for strategy components in a strategy |
JP2002510817A (en) * | 1998-04-03 | 2002-04-09 | トライアングル・ファーマシューティカルズ,インコーポレイテッド | System, method and computer program product for guiding treatment prescription plan selection |
US6584445B2 (en) * | 1998-10-22 | 2003-06-24 | Computerized Health Evaluation Systems, Inc. | Medical system for shared patient and physician decision making |
US6314415B1 (en) * | 1998-11-04 | 2001-11-06 | Cch Incorporated | Automated forms publishing system and method using a rule-based expert system to dynamically generate a graphical user interface |
EP1437674B2 (en) † | 1998-11-30 | 2011-11-23 | Novo Nordisk A/S | A method for assisting a user in a medical self treatment |
US6581038B1 (en) * | 1999-03-15 | 2003-06-17 | Nexcura, Inc. | Automated profiler system for providing medical information to patients |
US6269355B1 (en) * | 1999-04-15 | 2001-07-31 | Kadiri, Inc. | Automated process guidance system and method using knowledge management system |
US7030863B2 (en) * | 2000-05-26 | 2006-04-18 | America Online, Incorporated | Virtual keyboard system with automatic correction |
US7286115B2 (en) | 2000-05-26 | 2007-10-23 | Tegic Communications, Inc. | Directional input system with automatic correction |
US7821503B2 (en) | 2003-04-09 | 2010-10-26 | Tegic Communications, Inc. | Touch screen and graphical user interface |
US7750891B2 (en) | 2003-04-09 | 2010-07-06 | Tegic Communications, Inc. | Selective input system based on tracking of motion parameters of an input device |
US20030204426A1 (en) * | 1999-06-18 | 2003-10-30 | American Management Systems, Inc. | Decision management system which searches for strategy components |
US7058517B1 (en) | 1999-06-25 | 2006-06-06 | Genaissance Pharmaceuticals, Inc. | Methods for obtaining and using haplotype data |
DE1233364T1 (en) * | 1999-06-25 | 2003-04-10 | Genaissance Pharmaceuticals Inc., New Haven | Method for producing and using haplotype data |
US6708155B1 (en) * | 1999-07-07 | 2004-03-16 | American Management Systems, Inc. | Decision management system with automated strategy optimization |
US7376700B1 (en) * | 1999-08-23 | 2008-05-20 | Wellcoaches Corporation | Personal coaching system for clients with ongoing concerns such as weight loss |
US20040215491A1 (en) * | 1999-08-23 | 2004-10-28 | Clark Paul T. | Providing comprehensive online health-related information and services |
AU7606200A (en) * | 1999-09-23 | 2001-04-24 | Infoscriber Corporation | Medical information system and method to obtain reasoning for therapeutic events |
CA2387780C (en) * | 1999-10-15 | 2011-10-11 | W. Jean Dodds | Animal health diagnosis |
US8234099B2 (en) | 1999-10-15 | 2012-07-31 | Hemopet | Computer program for determining a nutritional diet product for a canine or feline animal |
US6730023B1 (en) * | 1999-10-15 | 2004-05-04 | Hemopet | Animal genetic and health profile database management |
US7548839B2 (en) * | 1999-10-15 | 2009-06-16 | Hemopet | System for animal health diagnosis |
US6287254B1 (en) | 1999-11-02 | 2001-09-11 | W. Jean Dodds | Animal health diagnosis |
US20050090718A1 (en) * | 1999-11-02 | 2005-04-28 | Dodds W J. | Animal healthcare well-being and nutrition |
US6876991B1 (en) | 1999-11-08 | 2005-04-05 | Collaborative Decision Platforms, Llc. | System, method and computer program product for a collaborative decision platform |
US7780619B2 (en) * | 1999-11-29 | 2010-08-24 | Nxstage Medical, Inc. | Blood treatment apparatus |
US20040204964A1 (en) * | 1999-12-06 | 2004-10-14 | Moore Erik Andrew | Method and apparatus for importing healthcare related information from a physician office management information system |
US6539250B1 (en) * | 1999-12-15 | 2003-03-25 | David S. Bettinger | Programmable transdermal therapeutic apparatus |
US8352289B2 (en) * | 1999-12-30 | 2013-01-08 | Dhi Computing, Inc. | Systems and methods for providing and maintaining electronic medical records |
US7774210B1 (en) * | 1999-12-30 | 2010-08-10 | DHI Computing Service, Inc. | Method and system for recording and maintaining patient history data as well as generating concurrent billing records |
KR20020077671A (en) * | 2000-01-06 | 2002-10-12 | 아이갓페인닷컴, 인크. | System and method of decision making |
CA2399011A1 (en) * | 2000-01-28 | 2001-08-02 | Acurian, Inc. | Systems and methods for selecting and recruiting investigators and subjects for clinical studies |
US6527713B2 (en) * | 2000-02-14 | 2003-03-04 | First Opinion Corporation | Automated diagnostic system and method including alternative symptoms |
AU2001240128A1 (en) * | 2000-03-10 | 2001-09-24 | Medidata Solutions, Inc. | Method of conducting secure clinical trials and guaranteeing the occurrence of an event |
JP2001273362A (en) * | 2000-03-23 | 2001-10-05 | Toshiba Corp | Medical diagnosis supporting method, system therefor, retrieval terminal and medical information terminal for the same |
US7025425B2 (en) * | 2000-03-29 | 2006-04-11 | University Of Virginia Patent Foundation | Method, system, and computer program product for the evaluation of glycemic control in diabetes from self-monitoring data |
US6687685B1 (en) * | 2000-04-07 | 2004-02-03 | Dr. Red Duke, Inc. | Automated medical decision making utilizing bayesian network knowledge domain modeling |
JP2001293058A (en) * | 2000-04-14 | 2001-10-23 | Takeo Kawai | Method and apparatus for indicating treatment data in musculature zone remedy |
AU2001259689A1 (en) * | 2000-05-09 | 2001-11-20 | Fair, ISAC and Company | Approach for re-using business rules |
US8301468B2 (en) * | 2000-05-15 | 2012-10-30 | Optuminsight, Inc. | System and method of drug disease matching |
US9183351B2 (en) | 2000-05-30 | 2015-11-10 | Vladimir Shusterman | Mobile system with network-distributed data processing for biomedical applications |
US8388530B2 (en) | 2000-05-30 | 2013-03-05 | Vladimir Shusterman | Personalized monitoring and healthcare information management using physiological basis functions |
US7801591B1 (en) | 2000-05-30 | 2010-09-21 | Vladimir Shusterman | Digital healthcare information management |
US7485095B2 (en) * | 2000-05-30 | 2009-02-03 | Vladimir Shusterman | Measurement and analysis of trends in physiological and/or health data |
AU2001265205A1 (en) | 2000-05-31 | 2001-12-11 | Fasttrack Systems, Inc. | Clinical trials management system and method |
US7444293B1 (en) * | 2000-05-31 | 2008-10-28 | Fasttrack Systems, Inc. | Protocol disambiguation using a model-based methodology |
US7337123B2 (en) * | 2000-06-26 | 2008-02-26 | Epic Systems Corporation | Rules based ticketing for self-scheduling of appointments |
US8688474B2 (en) * | 2000-06-26 | 2014-04-01 | Epic Systems Corporation | Patient health record access system |
US6931326B1 (en) | 2000-06-26 | 2005-08-16 | Genaissance Pharmaceuticals, Inc. | Methods for obtaining and using haplotype data |
DE60139496D1 (en) * | 2000-06-30 | 2009-09-17 | Becton Dickinson Co | HEALTH AND DISEASE MANAGEMENT SYSTEM FOR IMPROVED PATIENT SUPPLY |
US6742895B2 (en) * | 2000-07-06 | 2004-06-01 | Alan L. Robin | Internet-based glaucoma diagnostic system |
EP1172753A3 (en) * | 2000-07-15 | 2004-02-11 | Andrew William Bodsworth | Method for optimising pharmatheutical prescribing |
US7567870B1 (en) | 2000-07-31 | 2009-07-28 | Institute For Systems Biology | Multiparameter analysis for predictive medicine |
DE60136962D1 (en) * | 2000-08-22 | 2009-01-22 | Medtronic Inc | NETWORK-IMPLEMENTED MEDICAL SYSTEMS FOR REMOTE PATIENT MANAGEMENT |
WO2002023186A2 (en) * | 2000-09-15 | 2002-03-21 | Virco Bvba | System and method for optimizing drug therapy for the treatment of diseases |
US8050944B2 (en) * | 2000-09-20 | 2011-11-01 | Epic Systems Corporation | Intelligent patient visit information management and navigation system |
US7251610B2 (en) * | 2000-09-20 | 2007-07-31 | Epic Systems Corporation | Clinical documentation system for use by multiple caregivers |
US7447643B1 (en) | 2000-09-21 | 2008-11-04 | Theradoc.Com, Inc. | Systems and methods for communicating between a decision-support system and one or more mobile information devices |
WO2002025528A1 (en) | 2000-09-21 | 2002-03-28 | Theradoc.Com, Inc. | Systems and methods for manipulating medical data via a decision support system |
US20020095313A1 (en) * | 2000-09-28 | 2002-07-18 | Haq Mohamed M. | Computer system for assisting a physician |
US6988088B1 (en) * | 2000-10-17 | 2006-01-17 | Recare, Inc. | Systems and methods for adaptive medical decision support |
US6871171B1 (en) * | 2000-10-19 | 2005-03-22 | Optimata Ltd. | System and methods for optimized drug delivery and progression of diseased and normal cells |
US20020116222A1 (en) * | 2000-10-22 | 2002-08-22 | Standing Stone, Inc. | Method and system for administering anticoagulation therapy |
US20100211411A1 (en) * | 2000-10-31 | 2010-08-19 | Emergingmed.Com | System and method for matching users with a service provider, program, or program site based on detailed acceptance criteria |
US7711580B1 (en) | 2000-10-31 | 2010-05-04 | Emergingmed.Com | System and method for matching patients with clinical trials |
US20060136142A1 (en) * | 2000-11-02 | 2006-06-22 | Kurt Berlin | Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen based on the methylation status of the DNA |
WO2002037398A2 (en) * | 2000-11-02 | 2002-05-10 | Epigenomics Ag | Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens |
US20020055918A1 (en) * | 2000-11-08 | 2002-05-09 | Patrick Hlathein | Operating room resource management system incorporating an interactive, visual method for coordinating multiple, interdependent |
US7596541B2 (en) * | 2000-11-10 | 2009-09-29 | Medidata Solutions, Inc. | Method and apparatus of assuring informed consent while conducting secure clinical trials |
US20020082870A1 (en) * | 2000-11-20 | 2002-06-27 | Mark Penny | System and method for processing patient medical information |
US20050107672A1 (en) * | 2000-11-22 | 2005-05-19 | Recare, Inc. | System and method for external input of disease management algorithm |
US8301462B2 (en) * | 2000-11-22 | 2012-10-30 | Catalis, Inc. | Systems and methods for disease management algorithm integration |
CN1290053C (en) * | 2000-11-22 | 2006-12-13 | 里科尔公司 | Systems and methods for integrating disease management into physician workflow |
US7275220B2 (en) | 2000-12-22 | 2007-09-25 | Epic Systems Corporation | System and method for a seamless user interface for an integrated electronic health care information system |
US20020120472A1 (en) * | 2000-12-22 | 2002-08-29 | Dvorak Carl D. | System and method for integration of health care records |
US6983423B2 (en) * | 2000-12-22 | 2006-01-03 | Epic Systems Corporation | Electronic system for collecting and communicating clinical order information in an acute care setting |
US7181285B2 (en) | 2000-12-26 | 2007-02-20 | Cardiac Pacemakers, Inc. | Expert system and method |
US20030097185A1 (en) * | 2000-12-29 | 2003-05-22 | Goetzke Gary A. | Chronic pain patient medical resources forecaster |
US7373306B1 (en) | 2000-12-29 | 2008-05-13 | General Electric Capital Corporation | Systems and methods for tracking employee leaves under the FMLA |
US20020128866A1 (en) * | 2000-12-29 | 2002-09-12 | Goetzke Gary A. | Chronic pain patient care plan |
US20020128860A1 (en) * | 2001-01-04 | 2002-09-12 | Leveque Joseph A. | Collecting and managing clinical information |
US7412396B1 (en) | 2001-02-15 | 2008-08-12 | Haq Mohamed M | Virtual clinic for medical practice |
US20060235623A1 (en) * | 2001-01-19 | 2006-10-19 | Patrick Rambaud | Method of processing biological analysis data and expert system of biological analysis applying this method |
US20030014222A1 (en) * | 2001-02-28 | 2003-01-16 | Klass David B. | Method and system for monitoring patient care |
US20020138636A1 (en) * | 2001-03-23 | 2002-09-26 | Mark Buttner | Method for automatically mass generating personalized data report outputs |
US20020138746A1 (en) * | 2001-03-23 | 2002-09-26 | Mark Buttner | Method of generating a secure output file |
US20020143579A1 (en) * | 2001-03-30 | 2002-10-03 | Docherty John P. | System and method for targeted interventions of physician prescription practices based on deviations from expert guidelines |
US7181413B2 (en) | 2001-04-18 | 2007-02-20 | Capital Analytics, Inc. | Performance-based training assessment |
US20020187483A1 (en) * | 2001-04-20 | 2002-12-12 | Cerner Corporation | Computer system for providing information about the risk of an atypical clinical event based upon genetic information |
US7542961B2 (en) * | 2001-05-02 | 2009-06-02 | Victor Gogolak | Method and system for analyzing drug adverse effects |
US6778994B2 (en) * | 2001-05-02 | 2004-08-17 | Victor Gogolak | Pharmacovigilance database |
US7925612B2 (en) * | 2001-05-02 | 2011-04-12 | Victor Gogolak | Method for graphically depicting drug adverse effect risks |
US20020165898A1 (en) * | 2001-05-03 | 2002-11-07 | Joe Duffy | Recipient-determined method for sharing tasks in an advanced electronic messaging/workflow system |
US20020173993A1 (en) * | 2001-05-10 | 2002-11-21 | Decode Genetics Ehf. Corporation | Drug advice expert |
US7395214B2 (en) * | 2001-05-11 | 2008-07-01 | Craig P Shillingburg | Apparatus, device and method for prescribing, administering and monitoring a treatment regimen for a patient |
US20040015810A1 (en) * | 2001-05-23 | 2004-01-22 | Swinney Robert S. | Method for the improved provision of medical services |
DE10126715A1 (en) * | 2001-05-31 | 2002-12-12 | Siemens Ag | System for automated risk modification in risk groups |
WO2002100434A1 (en) * | 2001-06-07 | 2002-12-19 | The General Hospital Corporation | Treatment of neuropathic pain with n-methyl-d-aspartate (nmda) receptor antagonists |
EP1399867A2 (en) * | 2001-06-26 | 2004-03-24 | Siemens Aktiengesellschaft | Expert system for uncovering counter-indications in case of limited access to patient data |
JP4768960B2 (en) * | 2001-06-29 | 2011-09-07 | 株式会社ニュートリション・アクト | Nutritional requirement calculation device, nutritional supplement proposing device, nutritional supplement blending device, and nutritional supplement blending system |
US20030017440A1 (en) * | 2001-07-18 | 2003-01-23 | The Procter & Gamble Company | Methods for improving patient compliance with a treatment regimen |
US7343247B2 (en) * | 2001-07-30 | 2008-03-11 | The Institute For Systems Biology | Methods of classifying drug responsiveness using multiparameter analysis |
US20030061073A1 (en) * | 2001-08-01 | 2003-03-27 | Khiang Seow | Method and system for displaying patient information |
WO2003032827A1 (en) * | 2001-08-03 | 2003-04-24 | Robert Becker | Method for reliable measurement in medical care and patient self monitoring |
AU2002356033A1 (en) * | 2001-08-13 | 2003-03-03 | Genetics Development Corporation | A molecular diagnostic and computerized decision support system for selecting the optimum treatment for human cancer |
WO2003017174A1 (en) * | 2001-08-16 | 2003-02-27 | Wharton Robert H | Pictorial integrated prescription system |
EP1320322A1 (en) * | 2001-08-20 | 2003-06-25 | Inverness Medical Limited | Wireless diabetes management devices and methods for using the same |
US20030060691A1 (en) * | 2001-08-24 | 2003-03-27 | Olympus Optical Co., Ltd. | Examination follow-up information management apparatus for performing the simple and certain follow-up examinations |
US7461006B2 (en) * | 2001-08-29 | 2008-12-02 | Victor Gogolak | Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data |
US20030046113A1 (en) * | 2001-08-31 | 2003-03-06 | Johnson Ann Mond | Method and system for consumer healthcare decisionmaking |
US20030046111A1 (en) * | 2001-08-31 | 2003-03-06 | American Medical Systems | System and method for treating pelvic floor disorders |
US6802810B2 (en) * | 2001-09-21 | 2004-10-12 | Active Health Management | Care engine |
US20030065669A1 (en) * | 2001-10-03 | 2003-04-03 | Fasttrack Systems, Inc. | Timeline forecasting for clinical trials |
US7983848B2 (en) * | 2001-10-16 | 2011-07-19 | Cerner Innovation, Inc. | Computerized method and system for inferring genetic findings for a patient |
US7904314B2 (en) * | 2001-10-17 | 2011-03-08 | Siemens Medical Solutions Usa, Inc. | System and method for ordering patient specific healthcare services |
US7418374B2 (en) * | 2001-10-25 | 2008-08-26 | Optimata | Treatment protocol generation for diseases related to angiogenesis |
WO2003036590A1 (en) | 2001-10-26 | 2003-05-01 | Concordant Rater Systems Llc | Computer system and method for training, certifying or monitoring human clinical raters |
US8949082B2 (en) | 2001-11-02 | 2015-02-03 | Siemens Medical Solutions Usa, Inc. | Healthcare information technology system for predicting or preventing readmissions |
WO2003040987A2 (en) * | 2001-11-02 | 2003-05-15 | Siemens Corporate Research, Inc. | Patient data mining for lung cancer screening |
US7383088B2 (en) * | 2001-11-07 | 2008-06-03 | Cardiac Pacemakers, Inc. | Centralized management system for programmable medical devices |
US20030154110A1 (en) * | 2001-11-20 | 2003-08-14 | Ervin Walter | Method and apparatus for wireless access to a health care information system |
US20030130872A1 (en) * | 2001-11-27 | 2003-07-10 | Carl Dvorak | Methods and apparatus for managing and using inpatient healthcare information |
US7577573B2 (en) * | 2001-12-12 | 2009-08-18 | General Electric Company | Medical support system |
US7457731B2 (en) * | 2001-12-14 | 2008-11-25 | Siemens Medical Solutions Usa, Inc. | Early detection of disease outbreak using electronic patient data to reduce public health threat from bio-terrorism |
US20040267458A1 (en) * | 2001-12-21 | 2004-12-30 | Judson Richard S. | Methods for obtaining and using haplotype data |
FI20012593A0 (en) * | 2001-12-28 | 2001-12-28 | Pertti Laehteenmaeki | A method and system for providing a nutrition information service |
US20030135393A1 (en) * | 2002-01-11 | 2003-07-17 | Laboratory Corporation Of America Holdings | System, method and computer program product for improving treatment of medical patients |
US20030181792A1 (en) * | 2002-01-18 | 2003-09-25 | Robert Seyko | Healthcare outcome measurement, analysis and improvement system |
US20030171657A1 (en) * | 2002-01-22 | 2003-09-11 | Ralph Leonard | Selection of optimal medication methodology (SOOMM) |
US10173008B2 (en) | 2002-01-29 | 2019-01-08 | Baxter International Inc. | System and method for communicating with a dialysis machine through a network |
US7623969B2 (en) * | 2002-01-31 | 2009-11-24 | The Institute For Systems Biology | Gene discovery for the system assignment of gene function |
US20040205576A1 (en) * | 2002-02-25 | 2004-10-14 | Chikirivao Bill S. | System and method for managing Knowledge information |
US20030216945A1 (en) * | 2002-03-25 | 2003-11-20 | Dvorak Carl D. | Method for analyzing orders and automatically reacting to them with appropriate responses |
US20030220815A1 (en) * | 2002-03-25 | 2003-11-27 | Cathy Chang | System and method of automatically determining and displaying tasks to healthcare providers in a care-giving setting |
US20030220816A1 (en) * | 2002-04-30 | 2003-11-27 | Andy Giesler | System and method for managing interactions between machine-generated and user-defined patient lists |
US20030220821A1 (en) * | 2002-04-30 | 2003-11-27 | Ervin Walter | System and method for managing and reconciling asynchronous patient data |
US20030208380A1 (en) * | 2002-05-06 | 2003-11-06 | Honeycutt Sarah L. | System and method for delivering comprehensive health care |
US6830575B2 (en) * | 2002-05-08 | 2004-12-14 | Scimed Life Systems, Inc. | Method and device for providing full protection to a stent |
US20030220817A1 (en) * | 2002-05-15 | 2003-11-27 | Steve Larsen | System and method of formulating appropriate subsets of information from a patient's computer-based medical record for release to various requesting entities |
AU2003241484A1 (en) * | 2002-05-16 | 2003-12-31 | Gordon T. Morre | Checklist-based flow and tracking system for patient care by medical providers |
US20040010465A1 (en) * | 2002-05-20 | 2004-01-15 | Cliff Michalski | Method and apparatus for exception based payment posting |
US20040010422A1 (en) * | 2002-05-20 | 2004-01-15 | Cliff Michalski | Method and apparatus for batch-processed invoicing |
US7624029B1 (en) * | 2002-06-12 | 2009-11-24 | Anvita, Inc. | Computerized system and method for rapid data entry of past medical diagnoses |
US7698157B2 (en) * | 2002-06-12 | 2010-04-13 | Anvita, Inc. | System and method for multi-dimensional physician-specific data mining for pharmaceutical sales and marketing |
AU2003247529A1 (en) * | 2002-06-21 | 2004-01-06 | Ims Health Incorporated | Brand/generic classification system |
EP1378853A1 (en) * | 2002-07-04 | 2004-01-07 | GE Medical Systems Global Technology Company LLC | Digital medical assistance system |
WO2004008376A2 (en) * | 2002-07-17 | 2004-01-22 | Darazs Deborah L | Method and system for providing information to physicians |
US7979294B2 (en) * | 2002-07-31 | 2011-07-12 | Epic Systems Corporation | System and method for providing decision support to appointment schedulers in a healthcare setting |
US7840421B2 (en) | 2002-07-31 | 2010-11-23 | Otto Carl Gerntholtz | Infectious disease surveillance system |
US20030088365A1 (en) * | 2002-08-01 | 2003-05-08 | Robert Becker | System and method of drug development for selective drug use with individual, treatment responsive patients, and applications of the method in medical care |
JP5072182B2 (en) * | 2002-08-13 | 2012-11-14 | ユニヴァースティ オブ ヴァージニア パテント ファウンデイション | Method, system and computer program product for processing self-monitoring blood glucose (SMBG) data to promote diabetes self-management |
DE10237348A1 (en) * | 2002-08-14 | 2003-11-13 | Siemens Ag | Medical examination suggestion method in which a computer is used to compare a patient profile with a profile database, so that when the patient is in an examination department, additional examinations can be carried out |
EP1534122B1 (en) * | 2002-08-15 | 2016-07-20 | Pacific Edge Limited | Medical decision support systems utilizing gene expression and clinical information and method for use |
US20040044654A1 (en) * | 2002-08-29 | 2004-03-04 | Ballenger Eric S. | Methods for recruiting patients for clinical studies |
US7680086B2 (en) * | 2002-09-09 | 2010-03-16 | Siemens Canada Limited | Wireless local area network with clients having extended freedom of movement |
US8489336B2 (en) | 2002-09-16 | 2013-07-16 | Optimata Ltd. | Techniques for purposing a new compound and for re-purposing a drug |
WO2004025393A2 (en) * | 2002-09-16 | 2004-03-25 | Optimata, Ltd. | An interactive technique for optimizing drug development from the pre-clinical phases through phase-iv |
US20040172520A1 (en) * | 2002-09-19 | 2004-09-02 | Michael Smit | Methods and apparatus for visually creating complex expressions that inform a rules-based system of clinical decision support |
CA2506539A1 (en) * | 2002-11-20 | 2004-06-03 | Aventis Pharmaceuticals Inc. | Method and system for marketing a treatment regimen |
WO2004056271A2 (en) * | 2002-12-20 | 2004-07-08 | Koninklijke Philips Electronics N.V. | Method for determining normal measurements for a patient |
US7136707B2 (en) | 2003-01-21 | 2006-11-14 | Cardiac Pacemakers, Inc. | Recordable macros for pacemaker follow-up |
US7230529B2 (en) * | 2003-02-07 | 2007-06-12 | Theradoc, Inc. | System, method, and computer program for interfacing an expert system to a clinical information system |
WO2004074456A2 (en) | 2003-02-20 | 2004-09-02 | Mayo Foundation For Medical Education And Research | Methods for selecting medications |
US8688385B2 (en) | 2003-02-20 | 2014-04-01 | Mayo Foundation For Medical Education And Research | Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype |
SE0300893D0 (en) * | 2003-03-28 | 2003-03-28 | Saab Ab | Device, use, system and storage medium regarding decision support or control of an entity's actions |
US7260480B1 (en) * | 2003-04-07 | 2007-08-21 | Health Hero Network, Inc. | Method and system for integrating feedback loops in medical knowledge development and healthcare management |
US7543149B2 (en) * | 2003-04-22 | 2009-06-02 | Ge Medical Systems Information Technologies Inc. | Method, system and computer product for securing patient identity |
US20040267570A1 (en) * | 2003-04-23 | 2004-12-30 | Becker Robert E. | Method for information and management system for health care |
US7780595B2 (en) | 2003-05-15 | 2010-08-24 | Clinical Decision Support, Llc | Panel diagnostic method and system |
DE10322685A1 (en) * | 2003-05-20 | 2004-12-23 | Siemens Ag | Process for processing a data set comprising therapy instructions for medical treatments |
US20050015279A1 (en) * | 2003-05-21 | 2005-01-20 | Rucker Donald W. | Service order system and user interface for use in healthcare and other fields |
US8504380B2 (en) * | 2003-06-05 | 2013-08-06 | Medidata Solutions, Inc. | Assistance for clinical trial protocols |
US20050010444A1 (en) * | 2003-06-06 | 2005-01-13 | Iliff Edwin C. | System and method for assisting medical diagnosis using an anatomic system and cause matrix |
US20040260576A1 (en) * | 2003-06-20 | 2004-12-23 | Dongwen Wang | Guideline execution task ontology (GETO) |
WO2005002057A2 (en) * | 2003-06-23 | 2005-01-06 | On Command Corporation | Hybrid data distribution systems |
WO2005013019A2 (en) * | 2003-07-25 | 2005-02-10 | Yamaha Motor Co., Ltd | Soft computing optimizer of intelligent control system structures |
US20050038675A1 (en) * | 2003-08-12 | 2005-02-17 | Siekman Jeffrey A. | Methods and systems for at-home and community-based care |
WO2005029252A2 (en) * | 2003-09-15 | 2005-03-31 | Idx Systems Corporation | Executing clinical practice guidelines |
US20050059894A1 (en) * | 2003-09-16 | 2005-03-17 | Haishan Zeng | Automated endoscopy device, diagnostic method, and uses |
US20050071195A1 (en) * | 2003-09-30 | 2005-03-31 | Cassel David A. | System and method of synchronizing data sets across distributed systems |
US8825502B2 (en) * | 2003-09-30 | 2014-09-02 | Epic Systems Corporation | System and method for providing patient record synchronization in a healthcare setting |
US7240039B2 (en) * | 2003-10-29 | 2007-07-03 | Hewlett-Packard Development Company, L.P. | System and method for combining valuations of multiple evaluators |
US8029454B2 (en) | 2003-11-05 | 2011-10-04 | Baxter International Inc. | High convection home hemodialysis/hemofiltration and sorbent system |
US20050159985A1 (en) * | 2003-11-21 | 2005-07-21 | Bertram Carl T. | System and method of stratifying intervention groups and comparison groups based on disease severity index scores and ranges |
US20060047433A1 (en) * | 2004-08-24 | 2006-03-02 | Ishikawa Muriel Y | System and method related to enhancing an immune system |
US20060182742A1 (en) * | 2004-08-24 | 2006-08-17 | Ishikawa Muriel Y | System and method for magnifying a humoral immune response |
US20060047436A1 (en) * | 2004-08-25 | 2006-03-02 | Ishikawa Muriel Y | System and method for magnifying an immune response |
US20060122783A1 (en) * | 2004-08-24 | 2006-06-08 | Ishikawa Muriel Y | System and method for heightening a humoral immune response |
US20060122784A1 (en) * | 2004-12-03 | 2006-06-08 | Ishikawa Muriel Y | System and method for augmenting a humoral immune response |
US20060047434A1 (en) * | 2004-08-24 | 2006-03-02 | Ishikawa Muriel Y | System and method related to improving an immune system |
US20060047435A1 (en) * | 2004-08-24 | 2006-03-02 | Ishikawa Muriel Y | System and method related to augmenting an immune system |
US20060095211A1 (en) * | 2003-12-05 | 2006-05-04 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | System and method for modulating a cell mediated immune response |
US20060116824A1 (en) * | 2004-12-01 | 2006-06-01 | Ishikawa Muriel Y | System and method for modulating a humoral immune response |
US20060047437A1 (en) * | 2004-08-25 | 2006-03-02 | Ishikawa Muriel Y | System and method for heightening an immune response |
US20090240529A1 (en) * | 2003-12-27 | 2009-09-24 | Enhanced Care Initiatives, Inc. | Method for selecting a high risk patient for participation in a care management program for patients having poor prognoses |
US20050149362A1 (en) * | 2003-12-30 | 2005-07-07 | Peterson Per A. | System and method for visually presenting digital patient information for future drug use resulting from dosage alteration |
US20060143022A1 (en) * | 2004-01-13 | 2006-06-29 | Betty Bird | Consumer care management method and system |
WO2005073892A2 (en) * | 2004-01-16 | 2005-08-11 | Disease Management Services, Plc | Disease management system |
US20060080140A1 (en) * | 2004-02-09 | 2006-04-13 | Epic Systems Corporation | System and method for providing a clinical summary of patient information in various health care settings |
US7251638B2 (en) * | 2004-03-03 | 2007-07-31 | Yamaha Hatsudoki Kabushiki Kaisha | Intelligent robust control system for motorcycle using soft computing optimizer |
US20050216306A1 (en) * | 2004-03-24 | 2005-09-29 | Benjamin Atkinson | Evidence-based extender system |
US20050234741A1 (en) * | 2004-04-16 | 2005-10-20 | Sumit Rana | Electronic appointment scheduling for medical resources |
US8428968B2 (en) * | 2004-05-10 | 2013-04-23 | Epic Systems Corporation | Interactive system for patient access to electronic medical records |
US8135595B2 (en) * | 2004-05-14 | 2012-03-13 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Computer systems and methods for providing health care |
US20060004605A1 (en) * | 2004-06-21 | 2006-01-05 | Epic Systems Corporation | System and method for a comprehensive interactive graphical representation of a health care facility for managing patient care and health care facility resources |
US20050283387A1 (en) * | 2004-06-21 | 2005-12-22 | Epic Systems Corporation | System for providing an interactive anatomical graphical representation of a body for use in a health care environment |
US8060315B2 (en) * | 2004-07-27 | 2011-11-15 | Carefusion 303, Inc. | Method for measuring the incidence of hospital acquired infections |
US20070207492A1 (en) * | 2004-08-24 | 2007-09-06 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational methods and systems to adjust a humoral immune response |
US20070265819A1 (en) * | 2004-08-24 | 2007-11-15 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational methods and systems for improving cell-mediated immune response |
US20070265817A1 (en) * | 2004-08-24 | 2007-11-15 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems and methods relating to fortifying an immune system |
US20070265818A1 (en) * | 2004-08-24 | 2007-11-15 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational methods and systems for heightening cell-mediated immune response |
US20060257395A1 (en) * | 2005-05-16 | 2006-11-16 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | System and method for magnifying a humoral immune response |
US20070288173A1 (en) * | 2004-08-24 | 2007-12-13 | Searete Llc, A Limited Liability Corporation Of The State Of Delware | Computational methods and systems to reinforce a humoral immune response |
US20070198196A1 (en) * | 2004-08-24 | 2007-08-23 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems and methods relating to ameliorating an immune system |
US20060047554A1 (en) * | 2004-08-24 | 2006-03-02 | Steven Larsen | Rules based resource scheduling |
US20070196362A1 (en) * | 2004-08-24 | 2007-08-23 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational methods and systems to bolster an immune response |
US8725547B2 (en) | 2004-08-24 | 2014-05-13 | Epic Systems Corporation | Utilization indicating schedule scanner |
US20070265787A1 (en) * | 2004-08-24 | 2007-11-15 | Searete Llc,A Limited Liability Corporation Of The State Of Delaware | Computational methods and systems for magnifying cell-mediated immune response |
US20070265788A1 (en) * | 2004-08-24 | 2007-11-15 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational methods and systems for augmenting cell-mediated immune response |
US20060047439A1 (en) * | 2004-08-24 | 2006-03-02 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | System and method for improving a humoral immune response |
US20060047539A1 (en) * | 2004-08-31 | 2006-03-02 | Paul Huang | Healthcare administration transaction method and system for the same |
US20060053034A1 (en) * | 2004-09-08 | 2006-03-09 | Epic Systems Corporation | System and method for providing a real-time status for managing encounters in health care settings |
US7762181B2 (en) * | 2004-10-01 | 2010-07-27 | Fonterra Co-Operative Group Limited | Customised nutritional food and beverage dispensing system |
US20060085222A1 (en) * | 2004-10-14 | 2006-04-20 | Paul Huang | Healthcare administration transaction method and system for the same |
US20060085381A1 (en) * | 2004-10-20 | 2006-04-20 | Epic Systems Corporation | Remote deployment access system and method |
US9081879B2 (en) * | 2004-10-22 | 2015-07-14 | Clinical Decision Support, Llc | Matrix interface for medical diagnostic and treatment advice system and method |
US20060095315A1 (en) * | 2004-10-29 | 2006-05-04 | Sbc Knowledge Ventures L.P. | Method and apparatus for a mechanized attendance management system |
WO2006058103A2 (en) * | 2004-11-24 | 2006-06-01 | Siemens Medical Solutions Usa, Inc. | A predictive user interface system |
US20060117021A1 (en) * | 2004-11-29 | 2006-06-01 | Epic Systems Corporation | Shared account information method and apparatus |
US20060278241A1 (en) * | 2004-12-14 | 2006-12-14 | Gualberto Ruano | Physiogenomic method for predicting clinical outcomes of treatments in patients |
US7747392B2 (en) * | 2004-12-14 | 2010-06-29 | Genomas, Inc. | Physiogenomic method for predicting clinical outcomes of treatments in patients |
ITBO20050002A1 (en) * | 2005-01-04 | 2006-07-05 | Giacomo Vespasiani | METHOD AND SYSTEM FOR INTERACTIVE MANAGEMENT OF DATA CONCERNING AN INSULIN THERAPY IN SELF-CONTROL FOR A DIABETIC PATIENT |
US8140370B2 (en) * | 2005-01-20 | 2012-03-20 | Epic Systems Corporation | System and method for reducing the steps involved in searching for available appointment times and scheduling appointments in a health care environment |
US20060218108A1 (en) * | 2005-03-24 | 2006-09-28 | Sergey Panfilov | System for soft computing simulation |
US20060224547A1 (en) * | 2005-03-24 | 2006-10-05 | Ulyanov Sergey V | Efficient simulation system of quantum algorithm gates on classical computer based on fast algorithm |
US20080275731A1 (en) * | 2005-05-18 | 2008-11-06 | Rao R Bharat | Patient data mining improvements |
US20060293817A1 (en) * | 2005-06-23 | 2006-12-28 | Takahide Hagiwara | Intelligent electronically-controlled suspension system based on soft computing optimizer |
US20070021977A1 (en) * | 2005-07-19 | 2007-01-25 | Witt Biomedical Corporation | Automated system for capturing and archiving information to verify medical necessity of performing medical procedure |
US8392210B2 (en) * | 2005-07-28 | 2013-03-05 | Roberto Beraja | Medical claims fraud prevention system and associated methods |
US8751264B2 (en) | 2005-07-28 | 2014-06-10 | Beraja Ip, Llc | Fraud prevention system including biometric records identification and associated methods |
US8392211B2 (en) * | 2005-07-28 | 2013-03-05 | Roberto Beraja | Medical claims fraud prevention system including patient call initiating feature and associated methods |
US20160328812A9 (en) * | 2005-07-28 | 2016-11-10 | Roberto Beraja | Medical decision system including question mapping and cross referencing system and associated methods |
US8392212B2 (en) * | 2005-07-28 | 2013-03-05 | Roberto Beraja | Medical claims fraud prevention system including patient identification interface feature and associated methods |
US7464042B2 (en) * | 2005-07-28 | 2008-12-09 | Roberto Beraja | Medical professional monitoring system and associated methods |
US8392213B2 (en) * | 2005-07-28 | 2013-03-05 | Roberto Beraja | Medical claims fraud prevention system including historical patient locating feature and associated methods |
US8583454B2 (en) | 2005-07-28 | 2013-11-12 | Beraja Ip, Llc | Medical claims fraud prevention system including photograph records identification and associated methods |
US20070094133A1 (en) * | 2005-10-20 | 2007-04-26 | Sudhir Anandarao | Systems and methods for managing an expenditure cycle |
US20070203746A1 (en) * | 2005-10-24 | 2007-08-30 | Siemens Medical Solutions Health Services Corporation | System and user interface enabling user order item selection for medical and other fields |
CA2628108C (en) * | 2005-11-10 | 2020-01-07 | In Silico Biosciences, Inc. | Method and apparatus for computer modeling the human brain for predicting drug effects |
US20100305975A1 (en) * | 2005-11-14 | 2010-12-02 | Kantilal Kasan Daya | Pharmaceutical Packaging and Method for Delivery of Same |
US20070112593A1 (en) * | 2005-11-14 | 2007-05-17 | Rxcera Pharmaceutical, Inc. | Selection system, dispensing system and treatment with a one-a-day combination pill for hypertension, hypercholesterolemia, hypertriglyceridemia and anti-platelet treatment |
US20070112592A1 (en) * | 2005-11-17 | 2007-05-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Payments in providing assistance related to health |
US8468029B2 (en) * | 2005-11-17 | 2013-06-18 | The Invention Science Fund I, Llc | Subscriptions for assistance related to health |
US20070119928A1 (en) * | 2005-11-17 | 2007-05-31 | Jung Edward K | Generating a nutraceutical request from an inventory |
US20070112589A1 (en) * | 2005-11-17 | 2007-05-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | User interface for providing assistance related to health |
WO2007061707A2 (en) * | 2005-11-17 | 2007-05-31 | Searete Llc | Research in providing assistance related to health |
US8532938B2 (en) * | 2005-11-17 | 2013-09-10 | The Invention Science Fund I, Llc | Testing-dependent administration of a nutraceutical |
US10042980B2 (en) * | 2005-11-17 | 2018-08-07 | Gearbox Llc | Providing assistance related to health |
CA3060475A1 (en) * | 2005-11-29 | 2007-06-07 | Children's Hospital Medical Center | Optimization and individualization of medication selection and dosing |
US20070124176A1 (en) * | 2005-11-30 | 2007-05-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
US20080082272A1 (en) * | 2005-11-30 | 2008-04-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems and methods related to nutraceuticals |
US10296720B2 (en) * | 2005-11-30 | 2019-05-21 | Gearbox Llc | Computational systems and methods related to nutraceuticals |
US20070124175A1 (en) * | 2005-11-30 | 2007-05-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware. | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
US7927787B2 (en) * | 2006-06-28 | 2011-04-19 | The Invention Science Fund I, Llc | Methods and systems for analysis of nutraceutical associated components |
US20070174128A1 (en) * | 2005-11-30 | 2007-07-26 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging |
US20070289258A1 (en) * | 2006-06-14 | 2007-12-20 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Individualized pharmaceutical selection and packaging |
US20080052114A1 (en) * | 2005-11-30 | 2008-02-28 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems and methods related to nutraceuticals |
US8297028B2 (en) | 2006-06-14 | 2012-10-30 | The Invention Science Fund I, Llc | Individualized pharmaceutical selection and packaging |
US20080193919A1 (en) * | 2005-11-30 | 2008-08-14 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Systems and methods for receiving pathogen related information and responding |
US20110145009A1 (en) * | 2005-11-30 | 2011-06-16 | Jung Edward K Y | Methods and systems related to transmission of nutraceutical associatd information |
US20070124218A1 (en) * | 2005-11-30 | 2007-05-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems related to individualized nutraceutical selection and packaging |
US20070136092A1 (en) * | 2005-11-30 | 2007-06-14 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging |
US8340944B2 (en) * | 2005-11-30 | 2012-12-25 | The Invention Science Fund I, Llc | Computational and/or control systems and methods related to nutraceutical agent selection and dosing |
US20080114577A1 (en) * | 2005-11-30 | 2008-05-15 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational methods and systems associated with nutraceutical related assays |
US20080004905A1 (en) * | 2006-06-28 | 2008-01-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for analysis of nutraceutical associated components |
US20080103746A1 (en) * | 2005-11-30 | 2008-05-01 | Searete Llc, A Limited Liability Corporation | Systems and methods for pathogen detection and response |
US7974856B2 (en) * | 2005-11-30 | 2011-07-05 | The Invention Science Fund I, Llc | Computational systems and methods related to nutraceuticals |
US20080004909A1 (en) * | 2005-11-30 | 2008-01-03 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Computational systems related to nutraceuticals |
US8000981B2 (en) * | 2005-11-30 | 2011-08-16 | The Invention Science Fund I, Llc | Methods and systems related to receiving nutraceutical associated information |
US20070299693A1 (en) * | 2006-06-23 | 2007-12-27 | Searete Llc, A Limited Liability Corporation | Customized visual marking for medication labeling |
US7827042B2 (en) * | 2005-11-30 | 2010-11-02 | The Invention Science Fund I, Inc | Methods and systems related to transmission of nutraceutical associated information |
CN101394782B (en) * | 2006-01-05 | 2014-03-05 | 弗吉尼亚大学专利基金会 | System for evaluation of blood glucose variability in diabetes from self-monitoring data |
US20070173971A1 (en) * | 2006-01-26 | 2007-07-26 | Prairiestone Pharmacy, Llc | System and method of providing medication compliance packaging |
US7752060B2 (en) | 2006-02-08 | 2010-07-06 | Health Grades, Inc. | Internet system for connecting healthcare providers and patients |
US20070260631A1 (en) * | 2006-03-09 | 2007-11-08 | Microsoft Corporation | Embedded decision support |
US20070239488A1 (en) * | 2006-04-05 | 2007-10-11 | Derosso Robert | Computerized dental patient record |
US8380539B2 (en) * | 2006-05-09 | 2013-02-19 | University Of Louisville Research Foundation, Inc. | Personalized medicine management software |
US20070276197A1 (en) * | 2006-05-24 | 2007-11-29 | Lifescan, Inc. | Systems and methods for providing individualized disease management |
US20080086339A1 (en) * | 2006-06-23 | 2008-04-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Customized visual marking for medication labeling |
US20080015894A1 (en) * | 2006-07-17 | 2008-01-17 | Walgreen Co. | Health Risk Assessment Of A Medication Therapy Regimen |
US8478605B2 (en) * | 2006-07-17 | 2013-07-02 | Walgreen Co. | Appropriateness of a medication therapy regimen |
US20080126130A1 (en) * | 2006-07-17 | 2008-05-29 | Walgreen Co. | Compliance With A Medication Therapy Regimen |
US20080015549A1 (en) * | 2006-07-17 | 2008-01-17 | Siemens Medical Solutions Usa, Inc. | System For Processing Medication Restriction Information |
US20080015893A1 (en) * | 2006-07-17 | 2008-01-17 | Walgreen Co. | Identification of Inappropriate Medications In A Medication Therapy Regimen |
US8700430B2 (en) * | 2006-07-17 | 2014-04-15 | Walgreen Co. | Optimization of a medication therapy regimen |
US20080086337A1 (en) * | 2006-08-10 | 2008-04-10 | Patrick Soon-Shiong | Web based integrated information system for sharing patient medical information cross-organizationally |
CN101529453A (en) * | 2006-08-22 | 2009-09-09 | 领头马科技股份有限公司 | Medical assessment support system and method |
US8122432B2 (en) * | 2006-10-04 | 2012-02-21 | International Business Machines Corporation | Rule management using a configuration database |
US20080121743A1 (en) * | 2006-11-29 | 2008-05-29 | Fleckten Eric T | System For Pneumatically Conveying Particulate Material |
US20080154513A1 (en) * | 2006-12-21 | 2008-06-26 | University Of Virginia Patent Foundation | Systems, Methods and Computer Program Codes for Recognition of Patterns of Hyperglycemia and Hypoglycemia, Increased Glucose Variability, and Ineffective Self-Monitoring in Diabetes |
WO2008094790A1 (en) * | 2007-01-30 | 2008-08-07 | Global Grid, Llc | Method and apparatus for internet-based community of health experts |
US8201087B2 (en) | 2007-02-01 | 2012-06-12 | Tegic Communications, Inc. | Spell-check for a keyboard system with automatic correction |
US8225203B2 (en) | 2007-02-01 | 2012-07-17 | Nuance Communications, Inc. | Spell-check for a keyboard system with automatic correction |
US8758245B2 (en) * | 2007-03-20 | 2014-06-24 | Lifescan, Inc. | Systems and methods for pattern recognition in diabetes management |
US20080234943A1 (en) * | 2007-03-20 | 2008-09-25 | Pinaki Ray | Computer program for diabetes management |
US20080235053A1 (en) * | 2007-03-20 | 2008-09-25 | Pinaki Ray | Communication medium for diabetes management |
RU2512072C2 (en) * | 2007-04-13 | 2014-04-10 | Конинклейке Филипс Электроникс, Н.В. | Correlation of clinical events |
US8694441B1 (en) | 2007-09-04 | 2014-04-08 | MDX Medical, Inc. | Method for determining the quality of a professional |
WO2009049278A1 (en) * | 2007-10-12 | 2009-04-16 | Patientslikeme, Inc. | Self-improving method of using online communities to predict health-related outcomes |
US20090119130A1 (en) * | 2007-11-05 | 2009-05-07 | Zebadiah Kimmel | Method and apparatus for interpreting data |
US8447778B2 (en) | 2007-11-15 | 2013-05-21 | Siemens Medical Solutions Usa, Inc. | Adaptively optimizing order entry system |
BRPI0822212A2 (en) * | 2008-02-22 | 2015-06-23 | Lead Horse Technologies Inc | System and method for automatic ontology generation |
US20090240127A1 (en) * | 2008-03-20 | 2009-09-24 | Lifescan, Inc. | Methods of determining pre or post meal time slots or intervals in diabetes management |
CA2660307A1 (en) * | 2008-04-08 | 2009-10-08 | The Quantum Group, Inc. | System and method for dynamic drug interaction analysis and reporting |
US20090307006A1 (en) * | 2008-06-04 | 2009-12-10 | International Business Machines Corporation | Method of collaborative evaluation infrastructure to assess the quality of healthcare clnical decision actors |
US8057679B2 (en) | 2008-07-09 | 2011-11-15 | Baxter International Inc. | Dialysis system having trending and alert generation |
US9514283B2 (en) | 2008-07-09 | 2016-12-06 | Baxter International Inc. | Dialysis system having inventory management including online dextrose mixing |
US10089443B2 (en) | 2012-05-15 | 2018-10-02 | Baxter International Inc. | Home medical device systems and methods for therapy prescription and tracking, servicing and inventory |
US8168063B2 (en) | 2008-07-09 | 2012-05-01 | Baxter International Inc. | Dialysis system having filtering method for determining therapy prescriptions |
US8062513B2 (en) | 2008-07-09 | 2011-11-22 | Baxter International Inc. | Dialysis system and machine having therapy prescription recall |
WO2010018477A2 (en) * | 2008-08-15 | 2010-02-18 | Koninklijke Philips Electronics N.V. | Model enhanced imaging |
US8589178B2 (en) * | 2008-09-10 | 2013-11-19 | Roche Diagnostics Operations, Inc. | Extensible therapy delivery system and method thereof |
US8554579B2 (en) | 2008-10-13 | 2013-10-08 | Fht, Inc. | Management, reporting and benchmarking of medication preparation |
ES2927105T3 (en) * | 2008-10-20 | 2022-11-02 | Epitome Pharmaceuticals Ltd | Methods and systems to improve pharmaceutical intervention in coagulation control |
US20110276343A1 (en) * | 2008-11-06 | 2011-11-10 | Koninklijke Philips Electronics N.V. | Dynamic clinical worklist |
CN102203786A (en) * | 2008-11-06 | 2011-09-28 | 皇家飞利浦电子股份有限公司 | Executable clinical guideline and guideline tool |
US7794954B2 (en) | 2008-11-12 | 2010-09-14 | Hemopet | Detection and measurement of thyroid analyte profile |
US7799532B2 (en) * | 2008-11-12 | 2010-09-21 | Hemopet | Detection and measurement of thyroid hormone autoantibodies |
US8012769B2 (en) * | 2008-11-12 | 2011-09-06 | Hemopet | Thyroid analyte detection and measurement |
DE102008057910B4 (en) * | 2008-11-18 | 2010-10-07 | P&L Edv Systeme Gmbh | Patient management system with intelligent interface device for the transfer of medical data |
US20100151062A1 (en) * | 2008-12-16 | 2010-06-17 | Bruno Stefanon | Determining nutrients for animals through gene expression |
US7873482B2 (en) | 2008-12-16 | 2011-01-18 | Bruno Stefanon | Diagnostic system for selecting nutrition and pharmacological products for animals |
US20100274579A1 (en) * | 2009-04-22 | 2010-10-28 | Christian Marten | Dynamic, Interactive, Web-Based Treatment System |
WO2010126577A1 (en) | 2009-04-30 | 2010-11-04 | Patientslikeme, Inc. | Systems and methods for encouragement of data submission in online communities |
US10241644B2 (en) | 2011-06-03 | 2019-03-26 | Apple Inc. | Actionable reminder entries |
US10706373B2 (en) | 2011-06-03 | 2020-07-07 | Apple Inc. | Performing actions associated with task items that represent tasks to perform |
US9687639B1 (en) | 2009-06-28 | 2017-06-27 | Ronald Charles Krosky | Medical treatment |
WO2011002768A1 (en) * | 2009-06-30 | 2011-01-06 | Lifescan, Inc. | Analyte testing method and system |
US8926551B2 (en) * | 2009-07-07 | 2015-01-06 | Baxter Healthcare Inc. | Peritoneal dialysis therapy with large dialysis solution volumes |
AU2010270227B2 (en) * | 2009-07-08 | 2015-01-22 | Worldwide Innovative Network | Method for predicting efficacy of drugs in a patient |
US8751495B2 (en) * | 2009-09-29 | 2014-06-10 | Siemens Medical Solutions Usa, Inc. | Automated patient/document identification and categorization for medical data |
CN102034016B (en) * | 2009-09-30 | 2016-08-31 | 帕斯维基因组学公司 | Medication management system based on genome |
US20100077349A1 (en) * | 2009-11-06 | 2010-03-25 | Health Grades, Inc. | Patient direct connect |
US20110112850A1 (en) * | 2009-11-09 | 2011-05-12 | Roberto Beraja | Medical decision system including medical observation locking and associated methods |
US20110184761A1 (en) * | 2010-01-25 | 2011-07-28 | Siemens Medical Solutions Usa, Inc. | Method and Apparatus for Estimating Patient Populations |
US10943676B2 (en) | 2010-06-08 | 2021-03-09 | Cerner Innovation, Inc. | Healthcare information technology system for predicting or preventing readmissions |
WO2012002435A1 (en) * | 2010-06-30 | 2012-01-05 | 株式会社ニコン | Infection spread prevention support system, infection spread prevention support server, examination terminal, mobile terminal and program |
US20120016594A1 (en) * | 2010-07-02 | 2012-01-19 | Coriell Institute For Medical Research, Inc. | Method for translating genetic information for use in pharmacogenomic molecular diagnostics and personalized medicine research |
WO2012024450A2 (en) * | 2010-08-17 | 2012-02-23 | Wisercare Llc | Medical care treatment decision support system |
US20120078840A1 (en) * | 2010-09-27 | 2012-03-29 | General Electric Company | Apparatus, system and methods for comparing drug safety using holistic analysis and visualization of pharmacological data |
US20120101867A1 (en) * | 2010-10-25 | 2012-04-26 | Zgardovski Stanislav V | System for Automatic Assignment of Agents in Inbound and Outbound Campaigns |
US8719051B2 (en) * | 2011-01-13 | 2014-05-06 | Gear Five Health Solutions, Inc. | System and method for evaluating and comparing medical treatments |
US20140244292A1 (en) * | 2011-01-27 | 2014-08-28 | Wiser Together, Inc. | Method for Helping Patients Find Treatments Based on Similar Patients' Experiences |
EP3035222A1 (en) | 2011-03-10 | 2016-06-22 | Teva Pharmaceutical Industries Ltd. | A method, system and program for improved health care |
US20120239410A1 (en) * | 2011-03-17 | 2012-09-20 | Onmark, Inc. | Method, apparatus and computer program product for developing cost-effective, evidence-based treatment pathways using a data-driven approach |
US10057736B2 (en) | 2011-06-03 | 2018-08-21 | Apple Inc. | Active transport based notifications |
US20130018700A1 (en) * | 2011-07-14 | 2013-01-17 | International Business Machines Corporation | Optimizing product portfolios under customer choice |
US20140310025A1 (en) | 2011-11-21 | 2014-10-16 | Advanced Biological Laboratories Sa | Systems, methods, and computer program products for guiding the selection of therapeutic treatment regiments |
US20150006193A1 (en) * | 2011-12-23 | 2015-01-01 | Koninklijke Philips N.V. | Creating a personalized patient pathway |
US9235686B2 (en) * | 2012-01-06 | 2016-01-12 | Molecular Health Gmbh | Systems and methods for using adverse event data to predict potential side effects |
EP2648121A1 (en) * | 2012-04-03 | 2013-10-09 | Koninklijke Philips N.V. | Analyzing an action |
US20130268290A1 (en) * | 2012-04-02 | 2013-10-10 | David Jackson | Systems and methods for disease knowledge modeling |
CN103488858B (en) * | 2012-06-15 | 2017-03-22 | 国家卫生计生委科学技术研究所 | Contraception method selection expert evaluation method |
US10593000B2 (en) * | 2012-07-13 | 2020-03-17 | Koninklijke Philips N.V. | System and method for determining thresholds or a range of values used to allocate patients to a treatment level of a treatment program |
US20140025393A1 (en) * | 2012-07-17 | 2014-01-23 | Kang Wang | System and method for providing clinical decision support |
CA2881011A1 (en) * | 2012-08-03 | 2014-02-06 | Timeless Veterinary Systems, Inc. | Software tool for veterinarians |
US20140156539A1 (en) * | 2012-08-17 | 2014-06-05 | CrowdCare Corporation | Device Profile-Based Rule Making for Customer Care |
US20140081659A1 (en) | 2012-09-17 | 2014-03-20 | Depuy Orthopaedics, Inc. | Systems and methods for surgical and interventional planning, support, post-operative follow-up, and functional recovery tracking |
US10318635B2 (en) | 2012-09-28 | 2019-06-11 | Cerner Innovation, Inc. | Automated mapping of service codes in healthcare systems |
US10403391B2 (en) | 2012-09-28 | 2019-09-03 | Cerner Health Services, Inc. | Automated mapping of service codes in healthcare systems |
US10565315B2 (en) | 2012-09-28 | 2020-02-18 | Cerner Innovation, Inc. | Automated mapping of service codes in healthcare systems |
AU2013335278B2 (en) | 2012-10-26 | 2016-03-24 | Baxter Corporation Englewood | Improved work station for medical dose preparation system |
NZ707431A (en) | 2012-10-26 | 2016-05-27 | Baxter Corp Englewood | Improved image acquisition for medical dose preparation system |
US9833191B2 (en) | 2012-11-07 | 2017-12-05 | Bigfoot Biomedical, Inc. | Computer-based diabetes management |
US10262756B2 (en) | 2012-11-21 | 2019-04-16 | Humana Inc. | System for gap in care alerts |
US9351670B2 (en) | 2012-12-31 | 2016-05-31 | Abbott Diabetes Care Inc. | Glycemic risk determination based on variability of glucose levels |
US10383580B2 (en) | 2012-12-31 | 2019-08-20 | Abbott Diabetes Care Inc. | Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance |
US9579443B2 (en) | 2013-01-10 | 2017-02-28 | Fresenius Medical Care Holdings, Inc. | Peritoneal dialysis systems and related devices and methods |
KR20150113113A (en) * | 2013-01-29 | 2015-10-07 | 몰레큘러 헬스 게엠베하 | System and methods for clinical decision support |
US20140222512A1 (en) * | 2013-02-01 | 2014-08-07 | Goodsnitch, Inc. | Receiving, tracking and analyzing business intelligence data |
US20140229321A1 (en) | 2013-02-11 | 2014-08-14 | Facebook, Inc. | Determining gift suggestions for users of a social networking system using an auction model |
US9306896B2 (en) | 2013-02-11 | 2016-04-05 | Facebook, Inc. | Delivery of messages for a life event of user of social networking system |
DK3409201T3 (en) | 2013-03-15 | 2024-07-15 | Abbott Diabetes Care Inc | SYSTEM AND PROCEDURE FOR THE MANAGEMENT OF DIABETES BASED ON GLUCOSE MEDIAN, GLUCOSE VARIABILITY AND HYPOGLYCEMIC RISK |
US20140343982A1 (en) * | 2013-05-14 | 2014-11-20 | Landmark Graphics Corporation | Methods and systems related to workflow mentoring |
US10853451B2 (en) | 2013-06-06 | 2020-12-01 | Timeless Veterinary Systems International Limited | Drug formulary application |
CN103258308A (en) * | 2013-06-13 | 2013-08-21 | 宁飞鹏 | Home system of medical care community |
US10540448B2 (en) | 2013-07-15 | 2020-01-21 | Cerner Innovation, Inc. | Gap in care determination using a generic repository for healthcare |
US10726456B2 (en) | 2013-07-15 | 2020-07-28 | Aptitude, Llc | Method, apparatus, and computer program product for providing a virtual aggregation group |
US20150187228A1 (en) * | 2013-12-24 | 2015-07-02 | Precision Medicine Network, Inc. | Interactive medical education method and system |
US11257593B2 (en) | 2014-01-29 | 2022-02-22 | Umethod Health, Inc. | Interactive and analytical system that provides a dynamic tool for therapies to prevent and cure dementia-related diseases |
US10430555B1 (en) | 2014-03-13 | 2019-10-01 | Mckesson Corporation | Systems and methods for determining and communicating information to a pharmacy indicating patient eligibility for an intervention service |
US20170177834A1 (en) * | 2014-03-21 | 2017-06-22 | The Regents Of The University Of California | Nanomedicine optimization with feedback system control |
US10133996B2 (en) * | 2014-04-22 | 2018-11-20 | International Business Machines Corporation | Object lifecycle analysis tool |
US10144976B2 (en) | 2014-05-22 | 2018-12-04 | Case Western Reserve University | HIV-1 genotyping and coreceptor tropism assay |
CN106456870B (en) | 2014-06-10 | 2020-01-21 | 比格福特生物医学有限公司 | Insulin delivery system and method |
CA2961270A1 (en) * | 2014-09-14 | 2016-03-17 | League, Inc. | System and method for health providers to deliver programs to individuals |
US11107574B2 (en) | 2014-09-30 | 2021-08-31 | Baxter Corporation Englewood | Management of medication preparation with formulary management |
US10642957B1 (en) | 2014-10-21 | 2020-05-05 | Mckesson Corporation | Systems and methods for determining, collecting, and configuring patient intervention screening information from a pharmacy |
EP3937116A1 (en) | 2014-12-05 | 2022-01-12 | Baxter Corporation Englewood | Dose preparation data analytics |
JP6616419B2 (en) * | 2014-12-22 | 2019-12-04 | スミスズ メディカル エーエスディー,インコーポレイティド | Infusion planning system with clinical decision support |
US11948112B2 (en) | 2015-03-03 | 2024-04-02 | Baxter Corporation Engelwood | Pharmacy workflow management with integrated alerts |
US10691774B2 (en) | 2015-03-30 | 2020-06-23 | Cambia Health Solutions, Inc. | Systems and methods for a comprehensive online health care platform |
WO2016172801A1 (en) * | 2015-04-29 | 2016-11-03 | The University Of British Columbia | Clinical support system and method |
CN107810536B (en) | 2015-06-25 | 2023-01-24 | 甘布罗伦迪亚股份公司 | Medical device system and method with distributed database |
CN105512183B (en) * | 2015-11-24 | 2019-10-11 | 中国科学院重庆绿色智能技术研究院 | A kind of personalized recommendation method independently selected based on user and system |
US20170193157A1 (en) * | 2015-12-30 | 2017-07-06 | Microsoft Technology Licensing, Llc | Testing of Medicinal Drugs and Drug Combinations |
EP3223181B1 (en) | 2016-03-24 | 2019-12-18 | Sofradim Production | System and method of generating a model and simulating an effect on a surgical repair site |
US11185282B2 (en) * | 2016-05-20 | 2021-11-30 | Appmed Inc. | System and method for monitoring and identifying posology efficacy for an an individual |
US20180121617A1 (en) * | 2016-10-28 | 2018-05-03 | Pinscriptive, Inc. | Treatment Decision Interface Device and Graphical User Interface (GUI) |
US20180121616A1 (en) * | 2016-10-28 | 2018-05-03 | Pinscriptive, Inc. | Systems and Methods for Treatment Decisions |
CN110100283B (en) | 2016-12-21 | 2023-07-04 | 甘布罗伦迪亚股份公司 | Medical device system including information technology infrastructure with secure cluster domain supporting external domain |
US10589014B2 (en) | 2016-12-21 | 2020-03-17 | Baxter International Inc. | Medical fluid delivery system including remote machine updating and control |
US10964417B2 (en) | 2016-12-21 | 2021-03-30 | Baxter International Inc. | Medical fluid delivery system including a mobile platform for patient engagement and treatment compliance |
US10650380B1 (en) | 2017-03-31 | 2020-05-12 | Mckesson Corporation | System and method for evaluating requests |
US11404147B2 (en) | 2017-05-05 | 2022-08-02 | International Business Machines Corporation | Treatment recommendations based on drug-to-drug interactions |
US10839961B2 (en) | 2017-05-05 | 2020-11-17 | International Business Machines Corporation | Identifying drug-to-drug interactions in medical content and applying interactions to treatment recommendations |
CN107241429A (en) * | 2017-06-30 | 2017-10-10 | 江西博瑞彤芸科技有限公司 | Information interactive processing method and system |
US11610688B2 (en) | 2018-05-01 | 2023-03-21 | Merative Us L.P. | Generating personalized treatment options using precision cohorts and data driven models |
US11232872B2 (en) | 2018-06-06 | 2022-01-25 | Reliant Immune Diagnostics, Inc. | Code trigger telemedicine session |
US10636527B2 (en) * | 2018-06-06 | 2020-04-28 | Reliant Immune Diagnostics, Inc. | System and method for quantifying, ensuring, and triggering the prescriptive authority for a telemedicine session |
CN109192262B (en) * | 2018-09-17 | 2020-11-20 | 北京惠每云科技有限公司 | Data transmission method and device |
KR102293496B1 (en) * | 2018-10-31 | 2021-08-26 | 재단법인대구경북과학기술원 | System for cancer therapeutic recommendation using machine learning technique and method thereof |
WO2020092756A1 (en) * | 2018-11-01 | 2020-05-07 | The Methodist Hospital | System and method for automatically and continuously monitoring medication delivery to a patient |
US11894139B1 (en) | 2018-12-03 | 2024-02-06 | Patientslikeme Llc | Disease spectrum classification |
CN109743363A (en) * | 2018-12-18 | 2019-05-10 | 广州圆爱康生物科技有限公司 | A kind of medical information intelligently pushing method and device |
WO2020163441A1 (en) * | 2019-02-06 | 2020-08-13 | Optimdosing Llc | Smart multidosing |
CN110146704A (en) * | 2019-03-28 | 2019-08-20 | 苏州举健生物科技有限公司 | A kind of medication and pathological examination data system based on circulating tumor cell |
US11488027B2 (en) | 2020-02-21 | 2022-11-01 | Optum, Inc. | Targeted data retrieval and decision-tree-guided data evaluation |
JP6893052B1 (en) * | 2020-06-29 | 2021-06-23 | ゲノム・ファーマケア株式会社 | Dosing plan proposal system, method and program |
CN114661995A (en) * | 2022-03-28 | 2022-06-24 | 北京泽桥医疗科技股份有限公司 | Intelligent retrieval recommendation method for medical information |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4868763A (en) * | 1986-02-21 | 1989-09-19 | Hitachi, Ltd. | Knowledge-based system having plural processors |
US4839822A (en) * | 1987-08-13 | 1989-06-13 | 501 Synthes (U.S.A.) | Computer system and method for suggesting treatments for physical trauma |
JPH0271368A (en) * | 1988-09-06 | 1990-03-09 | Nec Corp | Cancer remedy planning device |
US5342922A (en) * | 1989-03-08 | 1994-08-30 | Washington University | Inhibitors of retroviral protease |
US5355444A (en) * | 1990-01-23 | 1994-10-11 | International Business Machines Corporation | Expert system wtih a plurality of independent knowledge bases |
JPH04166149A (en) * | 1990-10-31 | 1992-06-12 | Innovision Medical Inc | Device for displaying electronic image of nonstationary object |
US5299121A (en) * | 1992-06-04 | 1994-03-29 | Medscreen, Inc. | Non-prescription drug medication screening system |
US5694950A (en) * | 1992-08-21 | 1997-12-09 | J & W Mcmichael Software, Inc. | Method and system for use in treating a patient with immunosuppresants using whole blood level criteria to prevent an adverse immune response |
SE500122C2 (en) * | 1992-08-27 | 1994-04-18 | Rudolf Valentin Sillen | Method and apparatus for individually controlled, adaptive medication |
US5517405A (en) * | 1993-10-14 | 1996-05-14 | Aetna Life And Casualty Company | Expert system for providing interactive assistance in solving problems such as health care management |
US5660176A (en) * | 1993-12-29 | 1997-08-26 | First Opinion Corporation | Computerized medical diagnostic and treatment advice system |
US5594638A (en) * | 1993-12-29 | 1997-01-14 | First Opinion Corporation | Computerized medical diagnostic system including re-enter function and sensitivity factors |
US5737539A (en) * | 1994-10-28 | 1998-04-07 | Advanced Health Med-E-Systems Corp. | Prescription creation system |
US5845255A (en) * | 1994-10-28 | 1998-12-01 | Advanced Health Med-E-Systems Corporation | Prescription management system |
US5649070A (en) * | 1995-02-17 | 1997-07-15 | International Business Machines Corporation | Learning system with prototype replacement |
US5911132A (en) * | 1995-04-26 | 1999-06-08 | Lucent Technologies Inc. | Method using central epidemiological database |
JP3480940B2 (en) * | 1996-02-09 | 2003-12-22 | アデザ・バイオメデイカル・コーポレイシヨン | How to select medical and biochemical diagnostic tests using neural network related applications |
US6108635A (en) * | 1996-05-22 | 2000-08-22 | Interleukin Genetics, Inc. | Integrated disease information system |
US5924074A (en) * | 1996-09-27 | 1999-07-13 | Azron Incorporated | Electronic medical records system |
US5950630A (en) * | 1996-12-12 | 1999-09-14 | Portwood; Michael T. | System and method for improving compliance of a medical regimen |
US6021404A (en) * | 1997-08-18 | 2000-02-01 | Moukheibir; Nabil W. | Universal computer assisted diagnosis |
US5908383A (en) * | 1997-09-17 | 1999-06-01 | Brynjestad; Ulf | Knowledge-based expert interactive system for pain |
US6049794A (en) * | 1997-12-09 | 2000-04-11 | Jacobs; Charles M. | System for screening of medical decision making incorporating a knowledge base |
US6014631A (en) * | 1998-04-02 | 2000-01-11 | Merck-Medco Managed Care, Llc | Computer implemented patient medication review system and process for the managed care, health care and/or pharmacy industry |
JP2002510817A (en) * | 1998-04-03 | 2002-04-09 | トライアングル・ファーマシューティカルズ,インコーポレイテッド | System, method and computer program product for guiding treatment prescription plan selection |
-
1999
- 1999-04-01 JP JP2000542701A patent/JP2002510817A/en not_active Withdrawn
- 1999-04-01 WO PCT/US1999/007171 patent/WO1999052025A2/en not_active Application Discontinuation
- 1999-04-01 US US09/283,702 patent/US6081786A/en not_active Expired - Lifetime
- 1999-04-01 CN CN99806991A patent/CN1304512A/en active Pending
- 1999-04-01 AU AU34617/99A patent/AU750822B2/en not_active Ceased
- 1999-04-01 EP EP99916262A patent/EP1068568A4/en not_active Ceased
- 1999-04-01 BR BR9909906-3A patent/BR9909906A/en not_active Application Discontinuation
- 1999-04-01 IL IL13862099A patent/IL138620A0/en not_active IP Right Cessation
- 1999-04-01 CA CA2326579A patent/CA2326579C/en not_active Expired - Fee Related
-
2000
- 2000-03-10 US US09/523,532 patent/US6188988B1/en not_active Expired - Lifetime
-
2009
- 2009-08-17 JP JP2009188754A patent/JP4764500B2/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007124147A1 (en) | 2006-04-21 | 2007-11-01 | Medtronic Navigation, Inc. | Method and apparatus for optimizing a therapy |
EP2015845A1 (en) * | 2006-04-21 | 2009-01-21 | Medtronic Navigation, Inc. | Method and apparatus for optimizing a therapy |
EP2015845A4 (en) * | 2006-04-21 | 2015-07-08 | Medtronic Navigation Inc | Method and apparatus for optimizing a therapy |
CN111091908A (en) * | 2019-11-19 | 2020-05-01 | 泰康保险集团股份有限公司 | Auxiliary medical scheme generation method and device, storage medium and electronic equipment |
CN111091908B (en) * | 2019-11-19 | 2023-07-11 | 泰康保险集团股份有限公司 | Auxiliary medical scheme generation method and device, storage medium and electronic equipment |
Also Published As
Publication number | Publication date |
---|---|
EP1068568A4 (en) | 2004-10-27 |
WO1999052025A2 (en) | 1999-10-14 |
CN1304512A (en) | 2001-07-18 |
EP1068568A2 (en) | 2001-01-17 |
BR9909906A (en) | 2000-12-26 |
CA2326579C (en) | 2011-01-18 |
AU3461799A (en) | 1999-10-25 |
JP2002510817A (en) | 2002-04-09 |
IL138620A0 (en) | 2001-10-31 |
US6188988B1 (en) | 2001-02-13 |
US6081786A (en) | 2000-06-27 |
JP2010020784A (en) | 2010-01-28 |
WO1999052025A3 (en) | 1999-12-02 |
AU750822B2 (en) | 2002-08-01 |
JP4764500B2 (en) | 2011-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2326579A1 (en) | Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens | |
Chow et al. | Sample size calculations in clinical research | |
Rothwell et al. | From subgroups to individuals: general principles and the example of carotid endarterectomy | |
Bhattacharya et al. | Effectiveness of all-oral antiviral regimens in 996 human immunodeficiency virus/hepatitis C virus genotype 1–coinfected patients treated in routine practice | |
Hendriks et al. | Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation | |
Backus et al. | Comparative effectiveness of ledipasvir/sofosbuvir±ribavirin vs. ombitasvir/paritaprevir/ritonavir+ dasabuvir±ribavirin in 6961 genotype 1 patients treated in routine medical practice | |
Hogg et al. | Antiviral effect of double and triple drug combinations amongst HIV-infected adults: lessons from the implementation of viral load-driven antiretroviral therapy | |
Roe et al. | Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure | |
Rhone et al. | The antiviral effect of ritonavir and saquinavir incombination amongst HIV-infected adults: results from a community-based study | |
McCarty et al. | Factor Xa inhibitors: a novel therapeutic class for the treatment of nonvalvular atrial fibrillation | |
Chan et al. | Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics | |
Demler et al. | Maximizing clozapine utilization while minimizing blood dyscrasias: evaluation of patient demographics and severity of events | |
Padian et al. | The future of HIV prevention | |
Janczewska et al. | Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study | |
Kang et al. | Aspirin use in central retinal arterial occlusion to prevent ischaemic stroke: a retrospective cohort study in Taiwan | |
Lexchin | How safe and innovative are first-in-class drugs approved by Health Canada: a cohort study | |
Guo et al. | Non‐vitamin K antagonist oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with previous stroke or intracranial hemorrhage: A systematic review and meta‐analysis of observational studies | |
Kim et al. | A population genetic model for the initial spread of partially resistant malaria parasites under anti-malarial combination therapy and weak intrahost competition | |
Wang et al. | Identifying mutation‐driven changes in gene functionality that lead to venous thromboembolism | |
Meng et al. | Direct comparison of low-dose dabigatran and rivaroxaban for effectiveness and safety in patients with non-valvular atrial fibrillation | |
Lee et al. | Characterization of venous involvement in vasculo-Behçet disease | |
WO2002037398A3 (en) | Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens | |
Chiasson et al. | Rivaroxaban-induced hypersensitivity syndrome | |
Ovbiagele et al. | Secondary-prevention drug prescription in the very elderly after ischemic stroke or TIA | |
Plana et al. | Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20150401 |